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ABSTRACT 
 
 Removal of the initial GnRH administration within the 5-d CO-Synch + controlled 
internal drug release (CIDR) protocol (5dCO) on ovarian parameters and fixed timed 
artificial insemination (FTAI) pregnancy rates was investigated. In the first study, the 
objective was to evaluate the effects of GnRH removal on ovarian follicle dynamics and 
steroid hormone concentrations in non-lactating beef cows. Animals received either: 1) 
standard 5dCO hormone administration including 100 µg of GnRH at CIDR insertion and 
two concurrent, 25-mg doses of prostaglandin F2α (PGF2α) delivered at CIDR removal 
(G1-2PG), 2) no GnRH at CIDR insertion and two concurrent, 25-mg doses of PGF2α at 
CIDR removal (NoG1-2PG), or 3) no GnRH at CIDR insertion and a single, 25-mg dose of 
PGF2α at CIDR removal (NoG1-1PG). Cows in the NoG1-2PG treatment group displayed 
elevated peak plasma estradiol concentrations when compared to the NoG1-1PG 
treatment group with G1-2PG remaining intermediate. However, the remaining steroid 
hormone concentrations analyzed were not impacted by treatment. Furthermore, the 
ovarian parameters measured were not different among treatments. 
 In order to determine if fluctuations in estradiol concentrations observed in the 
first study would impact fertility, a field study was conducted. The objective of the field 
study was to evaluate the effect of initial GnRH removal at CIDR insertion on dominant 
follicle parameters and FTAI pregnancy rates in lactating beef cows. Cows were 
administered one of three treatments identical to the first study with the exception of 
xii 
 
FTAI occurring 72 h following CIDR removal. Although dominant follicle diameter was 
similar upon CIDR insertion, dominant follicle was greater in the NoG1-2PG treatment 
group upon CIDR removal. Estrous response prior to FTAI was not different among 
treatments, but NoG1-1PG did display more advanced (lower) estrous detection aid 
scores at FTAI. However, FTAI pregnancy rates did not differ among treatments.  
 In summary, the data from these two studies indicate that removal of the initial 
GnRH administration in the 5dCO does not negatively affect ovarian parameters or FTAI 
pregnancy rates. However, differences in dominant follicle diameter and changes in 
estradiol concentrations, as well as behavioral estrus, prior to FTAI warrant further 
research.  
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CHAPTER 1 
INTRODUCTION 
 
Reproductive efficiency is one of the largest drivers of profitability within beef 
cattle operations. One aspect that drives reproductive efficiency is timing of conception 
within the breeding season. Early conception can help drive profitability in the cow herd 
by resulting in increased longevity of breeding females and more uniformity with older 
and heavier calves at weaning (Funston et al., 2017). Multiple technologies are available 
to improve reproductive efficiency through increasing the number of females that 
conceive at the beginning of the breeding season (Patterson et al., 2017). Although 
these technologies exist, not all are cost effective and offer a return on time and money 
invested to implement them. Therefore, development and promotion of reproductive 
technologies should be performed with the understanding that return on investment 
will drive utilization and thus increase profitability on beef cattle operations.  
One of these technologies is artificial insemination (AI), which at only 10% 
utilization (NAHMS, 2009) continues to be a poorly received technology within beef 
cattle operations in the United States. The main reasons producers do not utilize AI is 
the shortage of time and labor needed to implement heat detection or estrous 
synchronization protocols.  To combat poor adoption rates of these technologies, 
multiple ovulation synchronization protocols have been developed to facilitate mass 
insemination of all females at a single predetermined time called fixed timed artificial 
insemination (FTAI). Fixed timed-AI allows producers to capture the value of AI, superior 
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genetics and improved calving distribution, while eliminating the labor-intensive 
requirements of estrus detection. The beneficial result of these protocols has been 
conception and pregnancy rates similar to many earlier developed, more time-
consuming, estrus detection-based synchronization protocols (Funston et al., 2017; 
Patterson et al., 2017). 
Specifically, the 5-d CO-Synch + controlled internal drug release (CIDR) protocol 
(5dCO) is a FTAI protocol that has proven efficacious with acceptable pregnancy rates 
when implemented in both beef and dairy females (Wilson et al., 2007; Bridges et al., 
2008; Santos et al., 2010). In addition, research by Bridges et al. (2008) has shown the 
5dCO to have advantageous FTAI pregnancy rates in Bos taurus females when compared 
to the more widely used 7-d CO-Synch + CIDR protocol. The standard 5dCO involves 
insertion of a CIDR and administration of an initial dose of gonadotropin releasing 
hormone (GnRH; G1) followed approximately 5 d later by CIDR removal and 
administration of two doses of prostaglandin F2α (PGF2α) approximately 8 h apart. Fixed 
timed- AI occurs 72 h following removal of CIDR and initial PGF2α administration 
(Johnson et al., 2013) concurrent with a second administration of GnRH (G2). 
The standard 5dCO, however, still lacks utilization among beef producers within 
the United States due to labor intensity and cost of additional exogenous hormones.  
Therefore, modifications to decrease handling time or frequency of hormone 
administration may prove to be advantageous and increase usage among producers. 
The requirement of two separate, 25-mg doses of PGF2α has recently been highlighted 
as an area for potential modification of the 5dCO. Kasimanickam et al. (2009) previously 
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demonstrated that pregnancy rates are detrimentally affected when only a single, 25-
mg dose of PGF2α is administered upon CIDR removal when compared to two separate, 
25-mg doses of PGF2α administered 7 h apart. The two separate, 25-mg doses of PGF2α 
are speculated to be required in beef cows to induce luteolysis of the 5-d old accessory 
corpus luteum (CL) created by the administration of G1 (Bridges et al., 2008; 
Kasimanickam et al., 2009). However, in heifers, a single, 25-mg dose of PGF2α has 
proven effective in engaging luteolysis of the 5-d accessory CL; and similar pregnancy 
rates were achieved upon FTAI when compared to heifers receiving two, separate, 25-
mg doses of PGF2α (Rabaglino et al., 2010; Cruppe et al., 2014; Kasimanickam et al., 
2014). The difference in response rates of the 5-d accessory CL to a single, 25-mg dose 
of PGF2α between cows and heifers has been thought to be due to an increased mg/kg 
of body weight dosing in heifers compared to cows (Bridges et al., 2012). Bridges et al. 
(2012) went on to further study this hypothesis when two concurrent, 25-mg doses of 
PGF2α was proven adequate to induce luteolysis of the 5-d accessory CL and produce 
similar FTAI pregnancy rates in cows when compared to females administered two, 
separate, 25-mg doses of PGF2α approximately 8 h apart. 
The requirement of G1 is the other area within the standard 5dCO where 
modifications have been researched. The administration of G1 is used to synchronize 
ovarian follicular growth at the start of the FTAI protocol as to better time and 
synchronize ovulation for optimal FTAI success. However, in beef cows, the response 
rate to a single GnRH injection is widely variable and ranges on average from 66 to 70% 
in both cycling and anestrus females (Geary et al., 2000; Atkins et al., 2010a; Atkins et al. 
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2010b; Bridges et al., 2014). The failure of response to the initial injection of GnRH has 
proven to be detrimental to pregnancy rates within the 7-d CO-Synch + CIDR protocol 
(Bridges et al., 2014) by leading to either smaller, immature dominant follicles (Lamb et 
al., 2001; Vasconcelos et al., 2001; Perry et al., 2005; Atkins et al., 2010a; Atkins et al. 
2010b) with decreased estradiol and progesterone concentrations or persistent follicles 
that are compromised in terms of both oocyte competence and steroidogenesis (Bridges 
et al., 2014). 
The design of the standard 5dCO more appropriately accommodates females 
that do not respond to G1 by shortening the period between G1 and corresponding 
CIDR removal and PGF2α administration compared to the 7-d protocol (Bridges et al., 
2008; Bridges et al., 2014). Therefore, the oocytes that do not respond to G1 would be 
younger and more competent. Furthermore, the lengthened proestrus phase is 
expected to increase estradiol concentrations and thus potentially increase FTAI 
pregnancy rates (Bridges et al., 2008). However, it remains unknown if failure of 
response to G1 would have similar effects between the 5dCO and the 7-d CO-Synch + 
CIDR protocol.  
When response to G1 within the standard 5dCO was analyzed in Bos taurus 
cows, Dias et al. (2014) reported that failure to respond to G1, or the lack of the 
creation of a new accessory CL, resulted in an increased behavioral estrus response and 
increased FTAI pregnancy rates when compared to animals that did respond to G1 by 
creating a new accessory CL. The Dias et al. (2014) research raised the question as to 
whether or not G1 is actually required within the 5dCO, since females not responding 
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have increased FTAI pregnancy rates. Thus, the actual requirement of G1 within the 
5dCO has been recently highlighted for further review.  
In dairy heifers, the elimination of G1 from the standard 5dCO resulted in no 
difference in FTAI pregnancy rates when compared to the standard 5-d CO-Synch +CIDR 
protocol (Lima et al., 2011; Kasimanickam et al., 2014). However, in beef heifers, the 
same contrast of treatments has mixed results. Cruppe et al. (2014) reported similar 
pregnancy rates in beef heifers, while Kasimanickam et al. (2014) reported that 
elimination of G1 resulted in decreased pregnancy rates in beef heifers when compared 
to the standard 5dCO. The inconsistent results, in beef heifers, leave an unanswered 
question as to the requirement of G1 within the 5dCO. Furthermore, few studies have 
looked at the requirements of G1 in the 5dCO when applied to beef cows.  
While acceptance rates of FTAI protocols remain low in the United States beef 
herd, continual modification to existing protocols may prove advantageous and increase 
utilization. The standard 5dCO remains an intensive protocol with high labor 
requirements and hormonal intervention. Although Bridges et al. (2012) could 
demonstrate that one time of handling could be eliminated by increasing the initial 
administration of PGF2α from 25 to 50 mg, further modification may prove 
advantageous through elimination of the number of hormones administered during 
application of this protocol. Removal of G1 would not only decrease the amount of 
pituitary hormone analog required but would also allow for PGF2α to be administered in 
a single, 25-mg dose thus eliminating the need for two concurrent, 25-mg doses. If G1 is 
not administered to reset the follicular wave, an accessory CL will not be created at the 
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initiation of the protocol. Thus, a second, 25-mg dose of PGF2α would not be required to 
induce luteolysis of a 5-d old accessory CL. Therefore, to potentiate a beneficial 
modification to the 5dCO, the effect of G1 removal on ovarian parameters and FTAI 
pregnancy rates in beef cows needs to be determined. 
  
7 
 
CHAPTER 2 
LITERATURE REVIEW 
 
2.1 Introduction 
 The following chapter of this thesis contains a review of literature relating to 
beef cattle reproduction and the development of estrous and ovulation synchronization 
programs. More specifically, the hormones and endocrine mechanisms involved in the 
estrous cycle are initially explained in detail, followed by a review of the estrous cycle, 
follicular development, and ovulatory wave formation. This is followed by a review of 
the development of estrous and ovulation synchronization with discussion of each 
protocol recommended for implementation by the Beef Reproduction Task Force. 
Further discussion on the specific development of the 5-d CO-Synch + CIDR protocol 
(5dCO) is followed by modifications sought to improve feasibility and implementation by 
beef producers. The review finishes with general discussion and the rationale for the 
research trails presented in the thesis.  
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2.2 Endocrinology 
2.2.1 Gonadotropin-releasing hormone 
The discovery of gonadotropin releasing hormone (GnRH) first occurred with the 
prediction of its existence in the late 1940’s and early 1950’s by G.W. Harris (1950). 
However, it would be two decades before the prediction came to fruition with the 
determination of the luteinizing hormone-releasing hormone, the classical name of 
GnRH, and structure as a decapeptide (Burgus et al., 1972). To date three isoforms of 
GnRH have been discovered (Fernald and White, 1999), however only the isoforms 
GnRH I and GnRH II are thought to be implicated in regulating the reproductive behavior 
in mammals with GnRH I being mainly responsible for gonadotropin release and 
reproductive function (Chen and Fernald, 2008). 
GnRH is synthesized in the hypothalamus by neurons located within the tonic 
center and surge center (Gorski, 1970) in response to multiple influences. GnRH, at this 
point in time, is believed to be stimulated by kisspeptin binding the G protein-coupled 
receptor 54 on the cell membrane and can be modulated by steroid hormones such as 
estradiol (Pielecka-Fortuna et al., 2008). Inhibition of GnRH can also occur through 
multiple mechanisms from neurotransmitters (corticotropin releasing hormone, 
gamma-amino butyric acid and β-endorphis; Ciechanowska et al., 2010) to steroid 
hormones such as progesterone. The tonic center (ventromedial nucleus and arcuate 
nucleus) is responsible for GnRH secretion in basal synchronized pulses throughout the 
luteal phase of the estrous cycle. The synchronized pulsatile releases of GnRH occur 
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every 30 to 120 minutes (Wang et al., 2010) into the median eminence of the 
perivascular space and travels through the capillaries into the hypothalmo-hypophyseal 
portal system (Chabbert-Buffet et al., 2000). Conversely, the surge center (preoptic 
nucleus, anterior hypothalamic area and suprachiasmic nucleus) initiates the pre-
ovulatory synthesis and release of GnRH. The substantial release of GnRH, 
corresponding with the end of the follicular phase of the estrous cycle, enters the 
capillaries and travels into the hypothalmo-hypophyseal portal system as previously 
explained. The hypothalmo-hypophyseal portal system flows from hypothalamus to the 
anterior pituitary gland where it acts on gonadotroph cells to stimulate the synthesis 
and release of gonadotropins, follicle stimulating hormone (FSH) and luteinizing 
hormone (LH; Wang et al., 2010).  
Even though GnRH has multiple separate ligands and receptor types, there is no 
link between the different isotypes and the specific GnRH receptor that they bind to 
(Chen and Fernald, 2008). The GnRH receptors located in the pituitary are 7-
transmembrane domain receptors (Seaflon et al., 1997; Chabbert-Buffet et al., 2000) 
that are unique members of the rhodopsin-like G protein-coupled receptor superfamily 
that in mammals have a relatively short third intracellular loop that lacks the 
intracellular carboxyl terminus (Wang et al., 2010). Binding of GnRH to its selected 
receptor initiates activation of the gonadotrophs in two ways: calcium influx and 
activation of the protein kinase C pathway (Ben-Menaham and Noar, 1994). The 
biphasic calcium influx initially spikes due to the release internal calcium stores and then 
is maintained through dependence upon L-type calcium channels (Stojilkovic et al., 
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1992). This high calcium influx is responsible for the synthesis of the unique β-subunit of 
LH (Weck et al., 1998). In contrast, the binding of GnRH activates the G proteins that 
simulate phospholipase C activity leading to protein kinase C and mitogen-activated 
protein kinase stimulation (Roberson et al., 1995). The mitogen-activated protein kinase 
pathway leads in to induction of the α-subunit (Weck et al., 1998) common amongst all 
gonadotropins. 
 
2.2.2 Pituitary hormones 
 The pituitary plays a critical role of intermediary between the hypothalamus and 
the gonads in reproductively active animals. As it was previously laid out the pituitary is 
the site of action of GnRH causing release in a pair of heterodimeric glycoprotein 
hormones, FSH and LH. Although both hormones are synthesized and secreted under 
the influence of GnRH they contrast in their actions at the level of the gonad. The 
specific actions of these hormones will be laid out in detail in the following sections. For 
generalization purposes, however, FSH is synthesized and secreted more frequently, 
resulting in shorter storage at the level of the pituitary (Apefelbaum and Taleisnik, 
1976). Luteinizing hormone in contrast is more abundantly stored within the anterior 
pituitary and thus, is synthesized at a lesser frequency but secreted in a greater volume 
(Muyan et al., 1994). Although contrasts between the two glycoproteins exist, it is 
important to note that they are both equally important to the function of the normal 
estrous cycle. 
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2.2.2.1 Follicle stimulating hormone 
Follicle stimulating hormone is a heterodimeric glycoprotein that consists of two 
subunits, α and β, joined by non-covalent forces. As stated earlier, the α-subunit is 
common amongst all the glycoprotein hormones (LH, thyrotropin, FSH and human 
choriogonadotropin) while the β subunit is unique for each of the separate hormones 
(Ryan et al., 1988).  
Synthesis and release of FSH occurs within the gonadotroph cells of the anterior 
pituitary, however the exact mechanism is not as well understood as its counterpart, LH. 
Primarily, pulsatile binding of GnRH to its receptor leads to stimulation of the 
gonadotroph to release FSH and LH, although FSH release has been shown to occur in 
the absence of GnRH stimulation (Padmanabhan et al., 1997). In addition, further 
studies have shown evidence that either GnRH isoforms (Padmanabhan et al., 2003) or 
pulsatility patterns may influence differences in LH and FSH secretion (Vizcarra et al., 
1999). Vizcarra et al. (1999) was able to demonstrate that LH secretion increased with 
increased exogenous GnRH pulsatility, while FSH increased at decreased GnRH 
pulsatility in nutritionally induced anovulatory, ovariectomized beef cows. Even though 
the exact mechanism for stimulation is still up for debate, the factors that lead to local 
and systemic inhibition of FSH release are more understood. The steroid hormone 
estradiol not only affects the secretion of GnRH but has been shown to have effects 
upon circulating FSH concentrations as well. In ovariectomized heifers, FSH 
concentrations can be suppressed by the administration of estradiol (Butler et al., 1983). 
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Furthermore, another glycoprotein, inhibin has also been shown to negatively affect 
circulating FSH concentrations when administered to ovariectomized heifers (Beard et 
al., 1990). Both hormones have been found to be secreted by the dominant follicle 
during the preovulatory period. 
FSH is released from the pituitary and travels through the circulatory system to 
the gonads where it interacts with its receptor. The FSH receptor is a transmembrane G 
protein-coupled receptor (Gundermann et al., 1995) that when bound activates the 
adenylyl cyclase/protein kinase A pathway (Simoni et al., 1997) leading to proliferation 
of the granulosa cells and increased aromatase activity, eliciting estrogen production, 
within said cell (Saumande, 1990). The overall effects of FSH binding its receptor in the 
gonads is extremely important in follicle recruitment and development in the female. 
Adams et al. (1992) showed that initiation of a new follicle wave would occur 
approximately 1 to 2 d following a surge in circulatory FSH concentrations. Furthermore, 
once a follicle is selected for dominance FSH leads to up-regulation of LH receptors on 
the granulosa cells (Ryle, 1972), allowing for maturation to begin. Therefore, elevated 
FSH concentrations around the time of antral follicular development and dominance 
may indicate the ability for FSH to facilitate early follicular development (Sunderland et 
al., 1994). 
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2.2.2.2 Luteinizing hormone 
Like FSH, LH is a heterodimeric glycoprotein that is comprised of an α-subunit, 
common to glycoprotein hormones, and a unique β subunit non-covalently bound 
together (Ryan et al., 1988). Gonadotroph cells of the anterior pituitary are responsible 
for the synthesis and release of LH in response to increased GnRH pulsatility and 
amplitude (Vizcarra et al., 1999). Therefore, following the actions of GnRH, circulatory 
LH concentrations vary depending upon stage of the estrous cycle. The progression of 
the estrous cycle causes a shift in LH from high frequency and low amplitude during the 
follicular and early luteal phases to a low frequency and high amplitude during the 
midluteal period (Rahe et al., 1980). Suppression of LH synthesis and secretion occurs 
through steroid hormones, specifically progesterone and estradiol, as a negative 
feedback mechanism. Increasing the circulating plasma levels of progesterone through 
exogenous use leads to suppressed LH pulsatility as noted in ovariectomized Holstein 
heifers (Beck et al., 1976). Estradiol, on the other hand, acts through a less understood 
mechanism to potentiate the actions of gonadotrophs regarding LH. Large single doses 
of estradiol have been shown to have a negative impact on LH pulsatility for a short 
period of time (Kesner et al., 1981). Oddly, Kesner et al. (1981) also found that 
suppression of LH with a bolus of estradiol was followed by surge in LH. This finding of 
an LH surge is more in line with evidence of estradiol having a positive feedback 
mechanism to promote LH pulse frequency (Stumpf et al., 1989). During the proestrus 
phase estradiol concentrations are at their highest and cause a surge of GnRH release 
(Karsch et al., 1997) as well as prime the pituitary to receive that GnRH (Clarke, 1988). 
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The sensitized pituitary along with the terminus deletion of the GnRH receptor in the 
anterior pituitary (Wang et al., 2010) is thought lead to the pre-ovulatory surge of LH. 
Luteinizing hormone binds to a G protein-coupled transmembrane receptor 
(Gundermann et al., 1995) at the level of the gonad. The effects of LH binding to the 
receptor can be varied depending upon the cell type as well as the stage of the estrous 
cycle and follicular wave. In the antral follicle, the theca cells are dependent upon LH to 
be able to further convert the steroid hormone progesterone into androstenedione 
(Smitz and Cortvrindt, 2002). As the follicle progresses and becomes selected for 
dominance the granulosa cells develop receptors for LH as well (Campbell et al., 1995). 
This switch of the follicle to LH dependence is needed for final maturation of the follicle 
(Driancourt, 2001) as well as ovulation in the presence of the preovulatory surge of LH 
(Evans et al., 1997). Once ovulation occurs LH stimulation is required for the 
development of a functional corpus luteum (CL; Peters et al., 1994) and subsequent 
progesterone secretion from the large and small luteal cells which can also be amplified 
by LH (Fitz et al., 1982). 
 
2.2.3 Steroid hormones 
 Steroid hormones play a key role as regulators of multiple physiological process 
of the body. All steroid hormones contain a steroid nucleus and are derivatives of 
cholesterol, a lipid molecule. While cholesterol can come from dietary sources, primarily 
it is formed endogenously by tissues such as the gonads from acetate (Morris and 
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Chaikoff, 1958). Once created steroid hormones are immediately released to execute 
their function upon the tissues. Typically, the steroid hormones are broken down into 
five groups according to their physiological behavior and the receptors to which they 
bind. The five groups of steroid hormones are: glucocorticoids, mineralocorticoids, 
androgens, estrogens, and progestins. For reproductive purposes, the most important of 
these (androgens, estrogens, and progestins) can be formed directly within the gonad. 
 
2.2.3.1 Estradiol 
Estradiol, as previously mentioned, is a steroid hormone synthesized and 
secreted by the granulosa cells of the dominant follicle. The granulosa cell requires the 
enzyme aromatase to convert testosterone to estradiol, which becomes activated when 
FSH binds to its receptor within the cell membrane (Saumande, 1990). Thus, one would 
assume that estradiol secretion would be tied to FSH pulsatility and subsequent effects, 
however such is not the case. Estradiol secretion has been associated with and found to 
follow pulsatile releases of LH (Rhodes et al., 1995). Rhodes et al. (1995) went on to 
show that maximal concentrations of estradiol appear 15 to 30 minutes following the 
peak pulses of LH. 
The mechanisms by which estradiol has its effects upon its target cell can vary 
greatly depending upon type of cell and location of the bound receptor. Classically 
steroid hormones are believed to act via intracellular or nuclear receptors that can 
function as transcription factors, but evidence has been presented for estrogen to also 
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have plasma membrane receptors that function through nongenomic effects such as 
second messengers, calcium and nitric oxide (Revankar et al., 2005). Regarding 
reproductive function, the main effects of estradiol include positive/negative hormonal 
feedback to the hypothalamus and pituitary (previously discussed), induce behavioral 
characteristics during estrus (Swanson and Hafs, 1971) and preparation of the uterus for 
pregnancy.  
The timing of onset of behavioral signs of estrus, as well as the specific behaviors 
displayed can fluctuate from animal to animal (Roelofs et al., 2005). Common behaviors 
that signify an animal is receptive to breeding are vaginal mucous discharge, 
restlessness, being mounted but not standing, sniffing vaginal area of other cows, 
resting chin on other cows, mounting cows and standing heat (Van Eerdenburg et al., 
1996). Increased estradiol concentrations with strong signs of behavioral estrus prior to 
artificial insemination have proven increase pregnancy rates in beef cattle, especially 
prior to induced ovulation with GnRH administration (Perry et al., 2005; Jinks et al., 
2012).  
 
2.2.3.2 Progesterone 
Progesterone, like estradiol, is a steroid hormone synthesized and secreted by 
the gonads, specifically the luteal cells of the CL (Fitz et al., 1982) in response to LH 
binding to its receptor on the cell membrane from d 2 to 12 of the estrous cycle, but 
does not respond to LH from d 12 to 17 (Peters et al., 1994). During this time, large 
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luteal cells are responsible for most of the progesterone production due to their ability 
to produce progesterone without the binding of LH to their receptors (Fitz et al., 1982). 
Within the luteal cells the activation of the adenylyl cyclase/protein kinase A pathway 
leads to the conversion of pregnenolone into progesterone via the enzyme 3β-
hydroxysteroid dehydrogenase (Koritz, 1964). 
Progesterone can have multiple systemic effects throughout the body, including 
those required for reproduction; modulation of the endometrium in preparation of 
implantation and the hypothalamic/pituitary hormones (Chabbert-Buffet et al., 2000). 
Two neuronal receptors have been described in literature, A and B, as well as presence 
of 7 transmembrane receptors (Brinton et al., 2008). Binding of the ligand to these 
receptors causes a cascade of events to occur resulting in transcriptional changes at the 
level of the genome, as well as indirect mechanism of action through opioidergic, 
cholinergic, and gamma amino butyric acid (GABA) systems. Progesterone effects on the 
hypothalamus neurons secreting GnRH are thought to work through the latter of the 
two mechanisms previously mentioned in bovine as they do not have receptors for 
progesterone (Chabbert-Buffet et al., 2000). Gamma amino butyric acid has been shown 
to have inhibitory effects on GnRH (Seilicovich et al., 1995) and LH (Gallegos-Sanchez et 
al., 1996) secretions, thus it was thought to be a possible mechanism for progesterone 
suppression of GnRH and LH. However, Skinner et al. (1999), has shown that the effects 
of progesterone on inhibition of GnRH take place through classical nuclear receptors in 
ovariectomized ewes. Furthermore, Skinner et al. (1998) showed in a previous study 
that the effects of progesterone on GnRH secretion require priming of the neurons by 
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estradiol. In that study animals that had no exposure to estradiol for 4 months prior to 
administration of progesterone resulted in non-suppressed LH concentrations. Animals 
that did receive estradiol exposure, for as little as two weeks, however did show LH 
suppression after progesterone administration. Therefore, estradiol and progesterone 
must work together to appropriately regulate hormonal secretion and inhibition in the 
hypothalamic-pituitary axis. 
At the level of the endometrium, progesterone leads to advances in gene 
expression to produce energy sources or contributors to histotroph (Forde et al., 2009). 
One such gene, DGAT2, is important in catalyzing acylcoenzyme A to triglyceride (Cases 
et al., 2001), a suspected energy source for the developing blastocyst (Ferguson and 
Leese, 2006). Furthermore, progesterone has been shown to induce glucose 
transporters within the uterine endometrium of ovine (Gao et al., 2009a; Gao et al., 
2009b). Thus, indicating the importance of progesterone for the development and 
growth of the conceptus. However, between d 7 and 13 of the estrous cycle, down 
regulation of progesterone receptors occurs within the lumen of the uterus (Kimmins 
and MacLaren, 2001). This down regulation of receptors also corresponds with an 
increase in genes associated with cell adhesion (Spencer et al., 2008), allowing for the 
uterus to further prepare for implantation. 
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2.3 Estrous Cycle 
2.3.1 Overview 
 The bovine estrous cycle consists of subsequent physiologic dynamics that occur 
approximately every 14 to 26 d with an average of 21 (Nellor and Cole, 1956). The exact 
length of the estrous cycle is influenced by many factors including age and breed. 
However, the number of follicular waves occurring during the estrous cycle seems to 
have a dominant impact on estrous cycle length (Sirois and Fortune, 1988). Follicular 
waves tend to last 7 to 10 d in length (Sirois and Fortune, 1988; Sunderland et al., 1994) 
and can occur two, three, or even up to four times per estrous cycle in Bos taurus 
species (Sirois and Fortune, 1988; Ginther et al., 1989; Sunderland et al. 1994). A large 
proportion of mature cows have two follicular waves per estrous cycle, while heifers 
have a higher tendency to have three waves per cycle (Rajamahendran et al., 1984; 
Townson et al., 2002). 
 The estrous cycle of the bovine is further broken down into two primary phases: 
the follicular phase and the luteal phase. Each of these phases are highly influenced by 
gonadotropins leading to the influence of steroidogenesis, folliculogenesis, ovulation, 
and CL function at the level of the ovary (Kojima, 2003). 
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2.3.2 Follicular phase 
 The follicular phase lasts for approximately 4 to 6 d characterized by the absence 
of a functional CL and presence of a preovulatory follicle. The follicular phase can be 
further divided down into proestrus (d 17 to 20) and estrus (d 21 to 1) periods 
(Sunderland et al., 1994; Forde et al., 2011). The proestrus period begins with the 
regression of the CL and ensuing decrease in circulating progesterone levels. The 
resulting effects of a decrease in the circulating concentrations of progesterone allows 
for removal of the negative feedback mechanism on gonadotropins. Rapid proliferation 
of the preovulatory follicle occurs during this period, as well as an increase in synthesis 
of estradiol (Forde et al., 2011). Increasing levels of estradiol production by the pre-
ovulatory follicle leads to positive feedback mechanisms at the level of the 
hypothalamus and pituitary (Stumpf et al., 1989). As previously discussed, the positive 
feedback of estradiol initiates an increase in LH frequency, allowing for maturation and 
growth of the preovulatory follicle (Adams et al., 2008). The transition to the estrus 
period begins as peak estradiol concentrations occur and the female exhibits sexual 
receptivity. Therefore, proestrus length is highly dependent upon the size of the 
preovulatory follicle at the time of luteolysis (Sirois and Fortune, 1988). 
 Behavioral estrus or female sexual receptivity, typically demarcated as d 0 of the 
estrous cycle, designates the estrus period of the follicular phase. At the time of estrus, 
or immediately preceding, peak estradiol concentrations are achieved (Chenault et al., 
1975). Peak estradiol concentrations lead to priming of the pituitary to GnRH (Clarke, 
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1988) and release of GnRH from the surge center of the hypothalamus (Karsch et al., 
1997). The resulting effects at the level of the pituitary cause a preovulatory surge of LH 
in the circulatory system approximately 2 to 6 h following onset of behavioral estrus 
(Chenault et al., 1975).  Ovulation of the dominant ovulatory follicle occurs after the LH 
surge, resulting in the total length of estrus, from behavioral onset to ovulation, to be 
between 25 and 35 h (Chenault et al., 1975). 
 
2.3.3 Luteal phase 
 The luteal phase makes up most of the estrous cycle, lasting from 14 to 18 d, and 
is demarcated by the presence of a functional CL producing progesterone on the ovary. 
Like the follicular phase the luteal phase can also be broken down into two periods: 
metestrus (d 2 to 4), and diestrus (d 5 to 17). The metestrus period begins immediately 
following ovulation as the corpus hemorrhagicum (CH) undergoes the process of 
luteinization. Following luteinization, luteal weight grows rapidly from d 3 to 6 of the 
estrous cycle and is closely mimicked by progesterone concentrations in circulating 
plasma (Erb et al., 1971). Once the CL becomes fully functional the transition from 
metestrus to diestrus occurs. During this time, peak progesterone concentrations in the 
circulatory system reach levels greater than 4 ng/mL around d 10 and that level is 
maintained until luteolysis occurs (Adams et al., 2008). Luteolysis or CL regression 
occurs in late diestrus, subsequently progesterone levels decrease and transition back to 
the follicular phase occurs. 
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2.3.4 Corpus luteum 
 The CL is the dominant structure on the ovary during the luteal phase (d 2 to 17) 
of the estrous cycle. Development of the corpus luteum occurs through the process of 
luteinization and creation of the small and large luteal cells. These luteal cells are 
influenced by gonadotropins to produce the steroid hormone progesterone that 
influences preparation of the uterus for pregnancy and negative feedback mechanisms 
at the level of the hypothalamus and pituitary (Chabbert-Buffet et al., 2000). Finally, 
regression occurs through the process of luteolysis, where the luteal cells go through 
apoptosis and secretion of progesterone decreases. 
 
2.3.4.1 Luteinization 
According to Smith et al. (1994) luteinizaiton is the transition of a preovulatory 
follicle, through remodeling and proliferation, into a vascular structure capable of 
progesterone secretion in large quantities. After rupture of the follicle, the follicular wall 
invaginates and breakdown of the basement membrane separating the granulosa and 
theca interna layer occurs allowing for migration of fibroblast, endothelial cells, and 
theca interna cells into more centralized positions with the developing CL (O’Shea et al., 
1980). Granulosa cells undergo hypertrophy to form large luteal cells and become the 
largest steroidogenic cells of the body, while theca interna cells develop into small luteal 
cells (O’Shea et al., 1980). Furthermore, it has been proposed that the smaller theca 
interna cells undergo mitosis and proliferate while the larger granulosa cells show no 
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evidence of mitosis (Smith et al., 1994; McCracken et al., 1999). Proliferation of the CL 
occurs rapidly from d 3 to d 6 and is followed by variable growth until reaching 
maximum size around d 15 of the estrous cycle as indicated by CL weights (Erb et al., 
1971). 
 
2.3.4.2 Steroidogenesis 
As previously stated in this review, progesterone is synthesized and secreted 
within the luteal cells of the CL in response to LH binding receptors on the cell wall. 
Therefore, it makes sense that Schallenberger et al. (1984) was able to show that 
progesterone is secreted in a pulsatile fashion that highly mimics that of the 
gonadotropins. Proportionally, small luteal cells express more LH receptors and thus in 
response to LH binding produce more progesterone (Ursely and Leymarie, 1979; 
Mamluk et al, 1998). However, overall small luteal cells tend to produce 20 times less 
total progesterone than large luteal cells (Ursely and Leymarie, 1979) due to the ability 
of large luteal cells to produce progesterone in the absence of LH binding to its 
receptors (Fitz et al., 1982). Therefore, large luteal cells are responsible for more than 
80% of the progesterone that is produced by the CL (Niswender et al. 1985). This is 
highly significant in the fact that the number of large luteal cells can greatly influence 
the total progesterone production achieved by the CL. Since large luteal cells are 
predominately formed by lutenization of the granulosa cells, larger ovulatory follicles 
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that contain greater numbers of granulosa cells result in larger concentrations of 
progesterone production during the following diestrus period (Perry et al., 2005).  
 
2.3.4.3 Luteolysis 
 If maternal recognition of pregnancy, via a viable conceptus, does not occur in 
the female, luteolysis ensues. In the absence of interferon-tau release from the 
conceptus (Bazer et al., 1994), the maternal recognition of pregnancy in bovine, tumor 
necrosis factor-α stimulates the uterine endometrium to secrete basal levels of the 
eicosanoid, prostaglandin (PG) F2α (PGF2α; Skarzynski et al., 2000). Tumor necrosis 
factor-α elicits its effects through the phospholipase A2 pathway in the stromal cells of 
the endometrium in the mid to late luteal phase (Okuda et al., 2004). Basal or sub-
luteolytic PGF2α secretion from the stromal cells travels to the CL and initiates a 
luteolytic cascade. Binding of PGF2α to receptors on the luteal cells causes activation of 
the phospholipase C pathway and an increase in intracellular Ca2+ (Davis et al., 1987). 
The resulting effect leads to a decrease in progesterone production, vasoconstriction, 
apoptosis and release of oxytocin (McCracken et al., 1999). Oxytocin released from the 
luteal cells travels via the countercurrent exchange between the ovarian vein and 
uterine artery (Hixon and Hansel, 1974) to bind receptors on the endometrium epithelial 
cells that have been up regulated due to progesterone and estradiol priming during the 
late luteal and early follicular phases (McCracken et al., 1984). Unlike tumor necrosis 
factor-α which can elicit effects during the mid-luteal, late luteal, and follicular phases, 
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oxytocin is only effective in stimulating PGF2α secretion by the uterine endometrium in 
the follicular phase (Skarzynski et al., 2000). However, upon binding the receptors of the 
endometrial epithelial cells oxytocin can induce a larger synthesis and pulsatile secretion 
of PGF2α. Furthermore, signals to initiate lysis of the CL are received in the posterior 
pituitary and subsequent neuroendocrine release of oxytocin occurs (McCraken et al., 
1999). The positive feedback mechanism of oxytocin initiating PGF2α secretion and PGF2α 
initiating oxytocin secretion work in cohesion to accelerate CL regression and a decline 
in progesterone production. 
 
2.4 Follicular Development 
2.4.1 Ovarian reserve 
 The ovarian reserve in females is comprised of a pool of primordial ovarian 
follicles that originate from primordial germs cells within the developing embryo. During 
gonadal development of the early embryo, the primordial germ cells migrate from the 
yolk sac epithelium through the gut mesentery to establish on the gonadal ridge of the 
mesonephros, proliferate, and form the pool of primordial follicles (Picton, 2001). The 
actual number of primordial germ cells that develop is highly variable based upon 
individual but is estimated to be around 2.1 x 106 cells at the end of the first trimester 
(Santos et al., 2013) and quickly goes through apoptosis to decline in number to around 
133,000 at birth (Erickson, 1966). Although, the preceding thought has been that the 
ovarian reserve is not renewable, recent work by Johnson et al. (2005) has shown that 
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bone marrow stem cells from general circulation can generate post-natal oogenesis in 
mice. However, whether the ovarian reserve is renewable or not, significant decreases 
occur after 4 years of age until the near zero state is achieved around 20 years of age in 
the bovine (Erickson, 1966). 
 
2.4.2 Follicular classification 
 Differentiation of the primordial germ cells into the oogonia occurs early in the 
developing embryo. Massive colonization of the fetal ovary with mesonephric cells 
occurs prior to the initiation of meiosis of the oocytes. The mesonephric cells are 
thought to form the precursors for follicular cells (Picton, 2001). During this process, 
oocytes become enclosed in a single squamous cell layer of pre-granulosa cells 
separated by a basement membrane from stromal cells, which eventually differentiate 
into theca cells (Orisaka et al., 2009). Oocytes that are not surrounded by the squamous 
cell granulosa cell layer degenerate, and nests of primordial follicles remain (Picton, 
2001). These primordial follicles form the basis for which further differentiation will 
occur to form the three categories of follicles widely recognized today: primary, 
secondary, and tertiary, antral or vesicular. 
 Differentiation of the primordial to primary follicle begins with the transition of 
the flattened pre-granulosa, or squamous, cells into cuboidal shaped granulosa cells that 
form a single cell layer around the primordial follicle and increase in number (Braw-Tal 
and Yossefi, 1997). Braw-Tal and Yossefi (1997) termed this initial growth phase I, with 
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changes in the shape and number of granulosa cells but diameter of the follicle 
remaining unchanged. Continued proliferation of the granulosa cells around the oocyte 
results in a layering formation. Once the oocyte attains two layers of granulosa cells it 
becomes classified as a secondary follicle (Aerts and Bols, 2010). The increase in 
granulosa number and layers, up to 6, was found to be high correlated with the growth 
of the oocyte during what was termed growth phase II by Braw-Tal and Yossefi (1997). 
As the follicle transitions to preantral, in their study, they found the oocyte diameter 
roughly doubled in size and differentiation of theca interna cells began to occur as well 
as formation of the zona pelucida. With the development of theca interna and granulosa 
cells a fluid filled vesicle forms, termed antrum, and the transitioning follicle is called a 
tertiary follicle (Erickson, 1966). As the antrum continues to grow, dominance is 
achieved and the follicle transitions into a Graffian or preovulatory follicle. The growth 
of the primordial follicle to ovulatory size has been estimated to take up to 180 d, with 
the development from the antral stage to preovulatory taking approximately 42 d 
(Lussier et al., 1987).  
 
2.4.3 Folliculogenesis 
 Ovarian follicle growth, or folliculogenesis, begins with the initiation of meiosis 
within the oocytes of the developing fetus. The primary oocyte progresses through 
meiosis to become arrested within the diplotene stage of the first prophase, where 
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proliferation of mitochondria and reorganization of the Golgi complex occurs, followed 
by entry into a quiescent state until puberty (Picton, 2001).  
The exact process for reinitiating folliculogenesis is still widely up for debate. 
However, follicular growth during the quiescent stage appears to be stalled due to 
inhibitors (Braw-Tal and Yossefi, 1997), suspected to be activin A (Braw-Tal, 2002). Upon 
the removal of the inhibitor basic fibroblast growth factor, kit ligand, growth 
differentiation factor 9, and bone morphogenic protein 15 secreted from the oocyte and 
local stromal/epithelial cells lead to the proliferation of and transition of flat to cuboidal 
granulosa cells, or growth phase I (Braw-Tal, 2002). Once the cuboidal granulosa cells 
proliferate to around 40 cells in the largest cross section, growth phase II is initiated 
(Braw-Tal and Yossefi, 1997) and the granulosa cells begin to express follistatin 
messenger ribonucleic acid (mRNA) and protein (Braw-Tal, 2002). Although it is 
suspected that kit ligand and follistatin from the granulosa cells are not the only factors 
involved (Braw-Tal, 2002) oocyte growth occurs along with continued granulosa cell 
proliferation in a highly-correlated fashion (Braw-Tal and Yossefi, 1997).  
Continued proliferation of the granulosa cells results in multiple layers forming 
around the oocyte. In addition, rapid growth of the oocyte induces the formation of the 
zona pellucida (Braw-Tal and Yossefi, 1997) and development of recognizable theca 
interna cells derived from the interstitial stroma as well as development into layers 
around the basal lamina occurs (Aerts and Bols, 2010). Up to this point, development of 
the preantral follicle has been accomplished in the absence of gonadotropin influence 
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(Braw-Tal and Yossefi, 1997). At the end of the preantral phase the highly vascularized 
external theca layer can provide the developing follicle with a supply of endocrine 
factors (Smitz and Cortvridnt, 2002). These endocrine factors, primarily LH and FSH, 
initiate the production of androgens within the theca interna and granulosa cells. 
Although the theca interna cells are not LH dependent for survival it is required to 
produce androstenedione which acts to cytodifferentiate response of the granulosa cell 
to FSH and promote follicle growth (Smitz and Cortvrindt, 2002). Once the follicles attain 
250 granulosa cells (Aerts and Bols, 2010) fluid filled spaces begin to appear within the 
granulosa cells and eventually coalesce to form a single crescent shaped antrum (Smitz 
and Cortvrindt, 2002).  
It is highly recognized that the antral follicle is dependent upon gonadotropins 
for further growth and development, however multiple other factors can modulate the 
action of these gonadotropins. Inhibin, activin, and follistatin are three of these key 
modulators that are produced within the now differentiated mural and cumulus 
granulosa cells (Smitz and Cortvrindt, 2002). Inhibin and activin are disulphide-linked 
glycoproteins that belong to the TGF-β superfamily and while follistatin is a functionally 
related glycoprotein, it does not belong to the same superfamily (Knight and Glister, 
2001). Activin works locally through promoting upregulation of FSH receptors and 
proliferation of the granulosa cells (Knight and Glister, 2001) but also down regulating 
steroidogenesis in theca cells (Wrathall and Knight, 1995). Inhibin, on the other hand, 
works in an opposing way to promote steroidogenesis from the theca cells (Wrathall 
and Knight, 1995) and, in concert with estrogen systemically, decrease synthesis and 
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release of FSH from the pituitary (Knight and Glister, 2001). The mechanism of action of 
follistatin, however, seems to be primarily through high-affinity binding of activin to 
inhibit steroidogenesis and follicular growth (Knight and Glister, 2001). Therefore, as 
follicles mature and inhibin production increases (Campbell et al., 1991) these local 
effects allow for increases in synthesis of androgens by the theca cells and sequential 
estrogen from granulosa cells.  
As the antral follicle continues to grow and transition into a dominant follicle, 
the granulosa cells develop LH receptors (Xu et al., 1995). This development is an 
important step, allowing for the continued growth of the follicle while FSH 
concentrations are declining (Ginther et al., 2003). Furthermore, Ginther et al. (2003) 
was able to show that circulating LH concentrations may increase around the time of 
selection (Ginther et al., 2003). The follicle continues to exponentially increase in size 
during the dominance phase and transcription begins to decline in the nucleus of the 
oocyte (Hyttel et al., 1997). However, final maturation of the oocyte does not occur until 
the LH surge. After the LH surge meiosis is resumed and germinal vesicle breakdown 
occurs (Knight and Glister, 2001). The oocyte progresses through the remaining stages 
of meiosis I and immediately enters meiosis II where it becomes arrested in the 
metaphase II stage (Hyttel et al., 1997) until fertilization. 
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2.4.4 Follicular wave characteristics 
 Follicular growth in the antral phase occurs in a wave-like pattern in many 
domestic species such as bovine. As previously stated the number and length of wave 
that an individual will have is highly dependent upon multiple factors such as age and 
breed. Bos taurus breeds tend to produce 2 to 3 follicular waves between ovulations 
(Savio et al., 1988; Ginther et al., 1989), while Bos indicus are more likely to have 3 to 5 
waves between ovulations (Sartori and Barros, 2011). Furthermore, as one would 
expect, the wavelength of the cycle is also dependent upon the number of cycles per 
wave. Two wave cows have longer periods of follicular growth, with emergence of 
waves on d 0 and 10 versus d 0, 9, 16 for two and three wave cows respectively (Ginther 
et al., 1989). Therefore, the increased wave length results in a longer period of growth 
and subsequent ovulation of larger follicles that are more mature (Townson et al., 
2002).  
 The wave-like pattern of follicular growth can be broken down into three 
separate phases: recruitment, selection, and dominance. The recruitment phase begins 
with the initiation of a follicular wave by an elevation of circulatory FSH (Adams et al., 
1992). During this phase, lasting from 1 to 3 d (Draincourt, 2001), a cohort of 
gonadotropin dependent follicles under 4 mm are stimulated to grow (Adams et al., 
1992). These follicles continue to grow under the influence of FSH until the selection 
phase occurs. To continue into the selection phase the follicles must function to support 
their own growth through estrogen production and inhibition of the remaining cohort, 
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resulting in atresia (Savio et al., 1988). The follicular selection phase results in 3 to 6 
competent follicle that continue to mature and grow (Fortune et al., 2001). During the 
selection and remaining dominant phase estradiol and inhibin negative feedback results 
in lower circulatory FSH concentrations (Adams et al., 1992). Decreased FSH 
concentrations results in the largest two follicles exhibiting increase growth rates at the 
end of the selection phase due to decreased FSH requirements (Ginther et al., 2001a) 
and the development of LH receptors in the granulosa cells (Xu et al., 1995). During this 
time, any remaining follicles that do not develop LH receptors regress by atresia due to 
continued inhibition by viable follicles via inhibin and estradiol (Guilbault et al., 1993). 
Transition to the dominance phase occurs once follicles reach 8.0 to 9.0 mm in diameter 
(Ginther et al., 1996) and is characterized by the growth of the largest follicle and 
regression of the remaining subordinate follicles. Although the exact mechanism is still 
unknown, selection for dominance is thought to be achieved by the first follicle to 
acquire LH receptors on its granulosa cells during the late selection period (Draincourt, 
2001). 
 As with the growth from recruitment to dominance, the resulting fate of the 
dominant follicle is highly dependent upon gonadotropin support. In the early to mid-
luteal phases of the estrous cycle progesterone production from the CL in cohesion with 
estradiol exerts a negative feedback on GnRH and LH (Skinner et al., 1998). Without the 
support of LH, the granulosa cells of the dominant follicle become atretic and growth is 
inhibited (Ginther et al., 2001b). However, in the absence of the negative feedback of 
progesterone during the final wave of the estrous cycle the dominant follicle will 
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become the preovulatory follicle and undergo ovulation (Ginther et al., 1989) and final 
maturation of the oocyte with the LH surge (Knight and Glister, 2001). 
 
2.5 Estrous Synchronization 
2.5.1 History and protocol development 
The first real research into manipulation of the estrous cycle in bovine began in 
early 1940’s when Casida et al. (1943) began injecting sheep pituitary extract into cattle 
to form a CL on the ovaries. This initial discovery of hormonal influence was quickly 
followed with studies showing progesterone inhibiting estrous (Christian and Casida, 
1948), failure for regression of the CL upon hysterectomy (Wiltbank and Casida, 1956), 
and regression of the CL in response to oxytocin (Armstrong and Hansel, 1959). These 
initial studies would lead the way for the next couple of decades for discovery of 
multiple hormones and the realization that the bovine estrous cycle could be 
manipulated to benefit reproduction.  
 
2.5.1.1 Progesterone 
The first true synchronization protocols came following the discovery of 
progesterone influence. Willet (1950) was able to report in abstract that a 50% 
conception rate was achieved following artificial insemination (AI) of dairy heifers after 
a progesterone-controlled estrus. However, the following studies into using 
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progesterone followed by insemination were unable to achieve those same results 
(Trimberger and Hansel, 1955; Nellor and Cole, 1956). Therefore, Nellore and Cole 
(1956) modified the protocol by using injections of 540 mg emulsified progesterone 
followed by 750 International Units (IU) of equine gonadotropin, known at the time to 
cause ovulation, which resulted in 89% of beef heifers exhibiting estrus during a 4 h 
period 1 d later. These animals were artificially inseminated 48 h after the equine 
gonadotropin injection resulting in the first recorded timed artificial insemination (TAI) 
(Nellor and Cole, 1956). 
 As knowledge on progesterone and its use for manipulation of the estrous cycle 
grew, synthetics developed and new protocols immerged. Hansel et al. (1961) fed 
lactating beef cattle 968 mg of medroxyprogesterone acetate (MAP) for 10 consecutive 
days followed by 500 mg of MAP for the next 10 consecutive days resulting in 91% of 
the animals detected in estrus or formed a CL during 3 to 5 d after the conclusion of the 
feeding period. The major downfall of this study, with only using progesterone, 
remained the lack of adequate pregnancy results (25%) following breeding at first 
estrus. However, Hansel et al. (1961) helped to firmly establish the use of a synthetic 
progesterone for inhibition of estrus. Zimbelman (1963) went on to set up dose 
response studies to determine an effective dose of MAP. He discovered that at doses of 
120 to 180 mg in a group feeding scenario, synchronization of ovulation occurred in 94% 
of beef heifers. Therefore 180 mg fed daily for 18 consecutive days was established as 
the effective oral dose and The Upjohn Company went on to commercialize the product 
as Repromix in 1965 (Lauderdale, 2009). However, the product was voluntarily pulled in 
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1967 due to the expensive price causing a lack of a market among commercial beef 
producers.  
At the same time, successful research continued into alternative oral 
progesterone synthetics such as chlormadinone acetate (Van Blake et al., 1963; Hansel 
et al., 1966) and melengestrol acetate (MGA; Zimbelman and Smith, 1966a). Zimbelman 
and Smith (1966a) found MGA to be extremely potent orally in comparison to MAP, 
being 300 to 900 times more potent, and an effective alternative. Furthermore, in 
consecutive papers Zimbelman and Smith (1966a; 1966b) were able to establish 0.4 mg 
daily as an effective oral dose to inhibit ovulation. However, the initial studies into MGA 
showed more promise for use as a growth promotant in prepubertal heifers (Bloss et al., 
1966; Zimbelman and Smith, 1966b). Bloss et al. (1966) exhibited that the best results 
for feed efficiency and weight gain were achieved at daily doses between 0.35 and 0.50 
mg daily. Therefore, the Food and Drug Administration (FDA) Center for Veterinary 
Medicine approved the use of MGA in 1968 for increased weight gain, improved feed 
efficiency, and suppression of estrus in confinement heifers at a rate of 0.25 to 0.5 mg 
daily (Food and Drug Administration, 1986). MGA use for estrous synchronization 
continued without approval as it was easily attained under the feedlot approved label.  
Approval for use in estrous synchronization finally occurred in 1997 (Food and Drug 
Administration, 1997a). 
Even though oral progesterone was effective for suppression of estrus, an 
alternative for more precise administration was desired. One of the first attempts for an 
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alternative used subcutaneous polyhydroxy polymer capsules containing 
norethandrolone (Nor) and achieved an estrus synchronization rate of 81.8% (Curl et al., 
1968). In addition, to more precisely control ovulation estrogen was being implemented 
into synchronization protocols (Lantz et al., 1968) as estrogen acts as a luteolytic agent 
when administered in the early estrous cycle (Wiltbank et al., 1971). Wiltbank et al. 
(1971) combined these two concepts using subcutaneous Nor implants for 9 d in the 
flank and subsequent injections of estradiol valerate at administration to achieve 93% 
estrus rate. Furthermore, when an injection of estradiol to 17β was added 24 h after 
implant removal, 98% of cycling heifers exhibited estrus within 48 h period with 100% 
ovulating in 36 h period (Wiltbank et al., 1971). Later, this same protocol was explored 
by Wiltbank and Gonzalez-Padilla (1975) and in a series of studies by Spitzer et al. 
(1978a; 1978b) and Miksch et al. (1978) where they replaced the Nor implant with a 
norgestomet implant in the ear to achieve satisfactory results. This initial research into 
the norgestomet implant and later followed by Spitzer et al. (1981) led to development 
of Syncro-Mate-B (SMB) and its approval for use by the FDA in 1982 (Food and Drug 
Administration, 1982). The SMB protocol consists of a 6 mg implant of norgestomet for 
9 d with and injection of 3 mg norgestomet and 5 mg estradiol valerate at time of 
implantation (Spitzer et al., 1981). 
Even though these products were effective, the desire for a more accurate and 
easily administrable progesterone source remained. As previously stated, oral 
progesterone proved hard to precisely dose and the alternative SMB implants had to be 
removed by surgically incising the ear. Therefore, a third option was developed, the 
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progesterone releasing intravaginal device (PRID). The PRID was first investigated by 
Roche (1976b) and was made up of salastic coils impregnated with 10% progesterone. 
When the PRID was inserted for 12 d with injections of 5 mg of estradiol benzoate and 
50 mg of progesterone at insertion, pregnancy rates were like control animals (Roche, 
1976a). Furthermore, this same concept was used to develop a controlled internal drug 
release (CIDR) that was impregnated with 1.38 mg of progesterone (Macmillan and 
Peterson, 1993) and approved by FDA in 1997 (Food and Drug Administration, 1997b) 
 
2.5.1.2 Prostaglandin F2α and gonadotropin releasing hormone 
Progesterone was not the only hormone being rapidly developed for estrous 
synchronization in the early 1970s. By the time of the Nellor and Cole (1956) experiment 
earlier discussed, as well as stated in the research by Armstrong and Hansel (1959), it 
was widely known that the pituitary played a crucial role in ovulation and hormonal 
secretion. Therefore, GnRH as well as LH had been discovered and classified by 1972 
(Gorski, 1970; Brugus et al., 1972) and was successful in synchronizing ovulation when 
used alone (Garverick et al., 1980) and when combined with progesterone (Kaltenbach 
et al., 1974). However, the real issue remained of how to consistently induce luteolysis 
of the CL. This was the main topic at the Second Brook Lodge Workshop where PGF2α 
was implicated as a possible initiator of luteolysis (Lauderdale, 2009). With emphasis 
placed on the need for its discovery PGF2α was soon implicated as the luteolytic factor of 
cattle (Lauderdale, 1972; Rowson et al., 1972; Louis et al., 1973). Lauderdale (1972) 
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reported that non-pregnant cows returned to estrus in 2 to 4 d following administration 
of PGF2α tromethamine salt (PGF2α THAM) from d 6 to 16 of the estrous cycle. 
Furthermore, Rowson (1972) was able to exhibit the analog chloprostenol was effective 
as well. 
Implementation of PGF2α and GnRH into estrous synchronization occurred 
rapidly. Although GnRH use was limited due to only approximately 66% to 70% of beef 
cows responding to a single injection (Geary et al., 2000), PGF2α proved quite 
advantageous. Lauderdale et al. (1974) was one of the first to implement a single 
injection dose of PGF2α THAM for estrous synchronization and TAI, reporting no 
difference in pregnancy rates between controls and those bred at estrus or TAI at 72 
and 90 h after PGF2α THAM administration. In addition, further studies at the time 
would go on to establish an effective dose of 25 mg for induction of CL regression 
(Lauderdale et al. 1977). However, single dose administration of PGF2α remained 
ineffective in animals that were within the first five days of the estrous cycle as 
described earlier. Therefore, early programs developed with additional injection of 
estradiol benzoate 48 h post PGF2α injection (Welch et al., 1975), with one study 
resulting in increased estrus detection to 90% with estradiol benzoate from 72% without 
(Peters et al., 1977), or a second dose of PGF2α 11 d following administration of the first 
PGF2α (Graves et al., 1974). These studies resulted FDA approval for PGF2α to be used for 
estrous synchronization in either a single dose (Food and Drug Administration, 1981) or 
consecutive doses 11 to 14 d apart (Food and Drug Administration, 1979). 
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2.5.1.3 Multiple hormone protocols 
Up to this point, most of the protocols developed for estrus synchronization only 
involved the use of a single hormone to achieve the desired routes. However, optimal 
enhancement of estrous synchronization is achieved under the influence of multiple 
hormones used in combination. Implantation of heifers with the SMB implant for 7 d 
with injection of PGF2α on d 7 at removal resulted in improved estrus synchronization 
and pregnancy results (Heersche et al., 1974). In addition, when the SMB implant was 
replaced with feeding MGA for 5 d, PGF2α injection on d 5, similar results were achieved 
(Lauderdale, 1975). The real advantage in these protocols revolved around the complete 
removal of progesterone influence at the end of the implant period due to CL regression 
during the implantation period or PGF2α injection (Odde, 1990). 
Combinations of MGA and PGF2α were proving to be effective in estrous 
synchronization protocols. Beal and Good (1986) were able to show cycling could even 
be induced successfully in non-cycling cows using this type of protocol. However, it was 
beginning to become apparent that estrus response could be reduced in cycling cows 
with both MGA (Beal et al., 1988) and SMB (Brink and Kiracofe, 1988) due to day of the 
cycle. Therefore, to circumvent issues with decreased pregnancy rates following 
progesterone treatment, Brown et al. (1988) developed a protocol where MGA was fed 
for 14 d and PGF2α was administered 16 to 17 d following the last MGA feeding. Moving 
the PGF2α injection to approximately 17 d after progesterone removal, a time point in 
late luteal phase, increases efficacy (Lauderdale, 1972). When compared to the SMB 
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protocol with PGF2α injection upon removal the 14 d MGA protocol increased pregnancy 
rates with no differences in estrus response (Brown et al., 1988). 
Clear advancements were being made with estrous synchronization, however, 
ovulation synchronization and TAI results remained subpar. Smith et al. (1984) was able 
to induce a tighter synchrony of estrus by injection of PGF2α 24 h prior to PRID removal.  
Furthermore, when the same protocol, PRID insert for 7 d with injection of PGF2α on d 6, 
was compared to two injections of PGF2α 11 d apart, estrus response rate and TAI 
pregnancy rates were increased significantly in the PRID group (Smith et al., 1984). In 
addition to PGF2α, studies using GnRH to induce ovulation had also shown advantages in 
TAI. When GnRH was given at either 30 h after progesterone removal with insemination 
at 6 and 12 h (Roche, 1974) or 18 h (Roche, 1976a) after GnRH injection, TAI pregnancy 
rates were increased when compared to progesterone alone, use of human chorionic 
gonadotropin, or estradiol benzoate. While both methods increased TAI pregnancy 
results, the real advancement came after development of transrectal ultrasonography 
and understanding of follicular waves. Using transrectal ultrasound resulted in the 
realization that precise estrus synchronization requires the control of both follicular 
waves and luteal lifespan (Patterson et al., 2007; Lauderdale, 2009). 
Thatcher et al. (1989) was able to further substantiate the fact that estrous 
synchronization would benefit from both follicular wave and luteal control. Using an 
injection of GnRH 7 d prior to PGF2α treatment resulted in a reduction of spontaneous 
estrus between injections, by inducing ovulation or atresia, and a tighter synchrony of 
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estrus following PGF2α (Thatcher et al., 1989). Implementation of this type of protocol, 
later known as Select Synch, allowed for a decreased need for estrus detection prior to 
PGF2α injection without decreasing pregnancy rates (Twagiramunga et al., 1992; Geary 
et al., 2000). Furthermore, with the addition of a second GnRH injection 48 h after PGF2α 
injection, synchronization of ovulation into an 8 h window could be effectively achieved 
(Pursley et al., 1995). This protocol would go on to become known as Ovsynch and was 
highly validated for TAI among dairy cows but not dairy heifers (Pursley et al., 1997). In 
addition, fertility was increased when animals were pre-synchronized with two 
injections of PGF2α or implementing two Ovsynch protocols 7 d apart (Souza et al., 
2008). When the Ovsynch was implemented in beef cows, Geary et al. (1998) showed 
increased pregnancy rates in Ovsynch treated cows compared to SMB treated cows, 
54% to 42% respectively. Furthermore, to make the protocol convenient for large scale 
beef implementation, Geary and Whitter (1997) performed TAI at or 24 h after the 
second GnRH injection and reported no differences in TAI pregnancy results. The 
concept of TAI at GnRH injection with the Ovsynch protocol would come to be more 
accepted in the beef industry and was termed the CO-Synch protocol (Patterson et al., 
2007). 
The remaining issue of the Ovsynch, Select Synch, or CO-Synch protocols was the 
lack of progesterone primer to initiate cycling in anestrous or prepubertal animals. 
Therefore, work into estrus synchronization of heifers remained concentrated on 
modifications of the MGA protocol. Initial work by Kesler et al. (1996) attempted to 
decrease the length of time from removal of MGA to PGF2α injection. However, it was 
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soon discovered that the optimal time for PGF2α injection would be 19 d following MGA 
removal (Lamb et al., 2000) due to the formation of overly mature, persistent follicles 
that would lead to decreased pregnancy rates. Although increased pregnancy rates 
were achieved with administration of PGF2α 19 d following MGA removal (Deutscher, 
2000), further modification into the MGA Select protocol by administration of GnRH on 
d 26 of the protocol resulted in tighter synchronization of estrus 48 to 72 h after PGF2α 
administration (Wood et al. 2001). 
 
2.5.1.4 Controlled internal drug release protocols 
The commercialization of the CIDR, vaginal progesterone device, and subsequent 
validation by Lucy et al. (2001) lead the next wave of development of estrous 
synchronization protocols, especially in the beef industry. The CIDR was quickly 
implemented into various protocols already in place to improve synchronization of non-
cycling animals. Addition of the CIDR into the CO-Synch protocol from the first GnRH 
administration to PGF2α administration resulted in increased pregnancy rates of 
anestrous cows and thus an increase in overall TAI pregnancy rates (Lamb et al., 2001). 
Further implementation of the CIDR into estrous synchronization by being used with a 
single PGF2α injection upon removal or with the Select Synch protocol continued to 
prove that it was an effective addition and resulted in adequate pregnancy results in 
beef cows (Larson et al., 2006). Furthermore, the addition of a second administration of 
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GnRH coinciding with AI would lead to the creation of a widely used fixed time AI (FTAI) 
protocol; 7-d CO-Synch + CIDR protocol. 
Using the CIDR to replace MGA in heifer protocols also proved effective. 
Increased synchrony of estrus and pregnancy rates were achieved with a CIDR Select 
protocol when compared to MGA Select protocol (Kojima et al., 2004). In addition, the 
CIDR Select protocol was proven to be equally as effective when a second GnRH 
injection was given at TAI, 72 h after PGF2α administration (Busch et al., 2007). It is 
important to note that in the CIDR Select protocol GnRH and PGF2α administration occur 
9 and 16 d after CIDR removal respectively due to decreased time to estrus following 
CIDR removal (Macmillan and Peterson, 1993). Furthermore, comparison of another set 
of similar protocols, the 14 d MGA protocol and 14 d CIDR protocol with PGF2α 
administration on d 19 and 16 respectively, resulted increased estrus expression and 
synchrony in heifers treated with the CIDR protocol while heifers with no difference in 
pregnancy rates between the two groups were identified (Tauck et al., 2007). When the 
two long-term CIDR protocols previously mentioned are compared directly, the 14 d 
CIDR protocol initiates an increased synchronization of estrus and conception to AI after 
estrus detection (Leitman et al., 2009), as well as increased conception to TAI (Mallory 
et al., 2011) over the CIDR Select protocol. Thus, suggesting the administration of GnRH 
is not required for synchronization of heifers within the two similar, long-term CIDR 
protocols. 
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More recently, protocols designed to more precisely align with follicular waves 
and prevent over maturation have been developed. Bridges et al. (2008) hypothesized 
that decreasing the interval between the initial GnRH and PGF2α as well as length of 
CIDR insertion within the CO-Synch plus CIDR protocol would enhance estrogen 
production and increase TAI pregnancy rates. Although the initial experiment showed 
no differences in pregnancy rates between the two treatments, in follow up 
experiments Bridges et al. (2008) was able to show increased pregnancy rates in the 
5dCO by adjusting TAI from 60 to 72 h after PGF2α administration and CIDR removal. In 
addition to the 5dCO, modification of the Select Synch protocol with CIDR has occurred 
to create a 6 d CIDR protocol. In the 6 d CIDR protocol PGF2α is administer 3 d prior CIDR 
insertion and GnRH injection to pre-synchronize heifers and initiate a new follicular 
wave at the start of the protocol (Grant et al., 2011). When compared to the Select 
Synch plus CIDR protocol, the 6 d CIDR protocol increased the percentage of heifers 
initiating a new wave at CIDR insertion and more synchronized follicle size at CIDR 
removal, as well as through ovulation resulting in tight synchrony of estrus (Grant et al., 
2011).  
Split-time AI has also recently been studied to see if TAI pregnancy results could 
be improved by extending interval from PGF2α injection to TAI an additional 20 h for 
animals not exhibiting estrus. Improvements in pregnancy rates were seen when 
insemination was delay for heifers on the 14 d CIDR protocol (Thomas et al., 2014). 
However, Thomas et al. (2014) was unable to exhibit the same results in beef cows on 
the 7-d CO-Synch protocol. Modifications to the current protocols continue to occur and 
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often, as in the case of the 5dCO, 6 d CIDR protocols, or split time AI, increased 
synchronization may require increased management and handling. 
 
2.5.2 Recommended protocols 
 With the rapid development of multiple protocols, the need arose to establish a 
common nomenclature and to facilitate transfer of the latest research into information 
to producers. Based upon these needs two organizations developed: Dairy Cattle 
Reproduction Council and Beef Reproduction Task Force. These groups consist of 
industry leaders, educators, researchers, veterinarians, and pharmaceutical 
representatives. These individuals come together to provide recommendations on 
reproductive technologies and synchronization protocols for their respective industries. 
Since this review is primarily focused for beef, the current synchronization protocols will 
cover those recommended by the Beef Reproduction Task Force and published by 
Johnson et al. (2013). 
 
2.5.2.1 Heat detection protocols 
 Animals within the heat detection protocols will display peak estrus 
approximately 48 to 72 h after PGF2α injection (Lauderdale, 1972). To accurately detect 
this estrus, heat detection must occur at minimum three times per day for a total 
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minimum time period of 3 h (Johnson et al., 2013). Animals detected in estrus should be 
AI approximately 6 to 12 h post first detected standing estrus.  
 1 Shot PG. Recommended for heifers. Animals within this protocol should 
undergo estrus detection and AI from d 0 through d 12 of the protocol. Animals not 
exhibiting estrus by d 5 should receive an injection of PGF2α. 
 Select Synch. Recommended for cows. Animals within this protocol will receive 
injections of GnRH on d 0 and PGF2α on d 7. Animals should undergo estrous detection 
and AI from d 6 though d 13 of the protocol.  
 Select Synch + CIDR. Recommended for cows. Animals within this protocol will 
receive a GnRH injection and CIDR insertion on d 0 and injection of PGF2α and removal of 
CIDR on d 7. Animals in this protocol should undergo estrus detection and AI from d 7 
through d 13 of the protocol. 
 7-d CIDR-PG. Recommended for heifers. Animals within this protocol will receive 
a CIDR on d 0, followed by removal and injection of PGF2α on d 7. Animals should 
undergo estrus detection and AI from d 7 through d 13 of the protocol. 
 PG 6-d CIDR. Recommended for cows. Animals within this protocol will receive 
PGF2α injection on d 0 followed by GnRH injection and CIDR on d 3. Removal of the CIDR 
occurs on d 9 with concurrent injection of PG. Animals should undergo estrus detection 
and AI from d 0 through d 3 and d 9 through d 12. Animals undergoing AI prior to CIDR 
insertion should discontinue the remainder of the protocol. 
47 
 
 MGA-PG. Recommended for heifers. Animals within this protocol will be fed 0.5 
mg of MGA from d 1 through d 14, followed by PGF2α injection 19 d later, or on d 33 of 
the protocol. Animals should undergo estrus detection and AI from d 33 through d 39 of 
the protocol. 
 
2.5.2.2 Heat detection & timed artificial insemination protocols 
 Animals within the heat detection and TAI protocols will undergo estrus 
detection and AI for approximately 3 d, followed by AI of all animals not exhibiting 
estrus on at a predetermined time point with concurrent injection of GnRH in those 
animals (Johnson et al., 2013). 
 Select Synch & TAI. Recommended for cows. Animals within this protocol will 
receive injections of GnRH on d 0 and PGF2α on d 7. Animals should undergo estrus 
detection and AI for 72 to 84 h after PGF2α injection followed by TAI and GnRH injection 
on animals not exhibiting estrus.  
 Select Synch + CIDR & TAI. Recommended for cows and heifers. Animals within 
this protocol will receive a GnRH injection and CIDR on d 0 and injection of PGF2α and 
removal of CIDR on d 7. Animals should undergo estrus detection and AI for 72 to 84 h 
after PGF2α injection followed by TAI and GnRH injection on animals not exhibiting 
estrus. 
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 PG 6-d CIDR & TAI. Recommended for cows. Animals within this protocol will 
receive PGF2α injection on d 0 followed by GnRH injection and CIDR insertion on d 3. 
Removal of the CIDR occurs on d 9 with concurrent injection of PG. Animals should 
undergo estrus detection and AI from d 0 through d 3 and 72 to 84 h after PGF2α 
injection followed by TAI and GnRH injection on animals not exhibiting estrus. Animals 
undergoing AI prior to CIDR insertion should discontinue the remainder of the protocol. 
 MGA-PG & TAI. Recommended for heifers. Animals within this protocol will be 
fed 0.5 mg of MGA from d 1 through d 14, followed by PGF2α injection 19 d later, or on d 
33 of the protocol. Animals should undergo estrus detection and AI for 72 to 84 h after 
PGF2α injection followed by TAI and GnRH injection on animals not exhibiting estrus. 
 14-d CIDR-PG & TAI. Recommended for heifers. Animals within this protocol will 
receive a CIDR on d 0 with removal occurring on d 14. Animals will receive and injection 
of PGF2α 16 d later, or on d 30 of the protocol. Animals should undergo estrus detection 
and AI for 70 to 74 h after PGF2α injection followed by TAI and GnRH injection on 
animals not exhibiting estrus. 
 
2.5.2.3 Fixed timed artificial insemination protocols 
 All animals in FTAI protocols will not be heat detected for estrus and will 
undergo AI insemination at a predetermined time point concurrent with an injection of 
GnRH (Johnson et al., 2013). All animals subjected to FTAI should be inseminated within 
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a 3 to 4 h period with the approximate average time of AI being equivalent to the listed 
time in the protocol. 
 7-d CO-Synch + CIDR. Recommended for cows and heifers. Animals within this 
protocol will receive a CIDR and injection of GnRH on d 0 followed by removal of the 
CIDR with concurrent injection of PGF2α on d 7. Cows should undergo FTAI and injection 
of GnRH 60 to 66 h after injection of PGF2α. Heifers should undergo FTAI and injection of 
GnRH approximately 54 h after injection of PGF2α. 
 5-d CO-Synch + CIDR. Recommended for cows. Animals within this protocol will 
receive a CIDR and injection of GnRH on d 0 followed by removal of the CIDR with 
concurrent injection of PGF2α on d 5 and a second injection of PGF2α 8 h later. Animals 
should undergo FTAI and injection of GnRH approximately 72 h after injection of the first 
PGF2α. Interval between first PGF2α injection and FTAI should be shortened to 
approximately 66 h in Bos Indicus animals.  
 MGA-PG. Recommended for heifers. Animals within this protocol will be fed 0.5 
mg of MGA from d 1 through d 14, followed by PGF2α injection 19 d later, or on d 33 of 
the protocol. Animals should FTAI and injection of GnRH approximately 72 h after PGF2α 
injection. 
 14-d CIDR-PG. Recommended for heifers. Animals within this protocol will 
receive a CIDR on d 0 with removal occurring on d 14. Animals will receive and injection 
of PGF2α 16 d later, or on d 30 of the protocol. Animals should undergo FTAI with 
concurrent injection of GnRH approximately 66 h following PGF2α injection. 
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2.6 5-d CO-Synch CIDR Protocol 
2.6.1 Development 
 The inclusion of the CIDR and subsequent development of the 7-d CO-Synch + 
CIDR protocol quickly became the dominant estrous synchronization protocol that was 
researched, as well as recommended for use by the Beef Reproduction Task Force 
(Lamb, 2008). However, 40 to 50% of the females subjected to this protocol still failed to 
conceive to TAI in many of the early studies (Lamb et al. 2001; Martinez et al., 2002; 
Larson et al., 2006). Therefore, room remained for improvements in the 7-d CO-Synch + 
CIDR protocol to increase TAI pregnancy results to FTAI. 
 One of the major drawbacks to any estrous synchronization protocol that uses 
GnRH on the onset of the protocol is that only 66 to 70% of beef cows have been shown 
to respond to that initial injection of GnRH (Geary et al., 2000). Animals past d 2 of the 
estrus cycle that do not respond to the initial injection of GnRH have significantly 
smaller follicles with less estradiol production at timing of the second injection of GnRH 
(Atkins et al., 2010a).  Smaller follicles and lower estradiol concentrations have been 
shown to have decreased conception and embryonic survival rates to induced GnRH 
ovulation when compared to large follicles and spontaneous ovulations (Perry et al., 
2005; Mussard et al., 2007). Potential exists that follicles not responding to GnRH may 
be undergoing atresia resulting in follicular wave turnover later than those that respond 
to GnRH. Conversely, they may also be immature, lacking LH receptors, and become 
over maturated prior to the second injection of GnRH (Atkins et al., 2010b). Both 
51 
 
outcomes potentially decrease fertility at time of second GnRH injection and therefore, 
further research was needed to understand the follicular size and age contributions to 
fertility. 
 Based upon a series of results from experiments looking in to the effect of 
follicular size and age, evidence began to develop that the length of proestrus was more 
influential on conception rates than either of the previous two variables (Bridges et al., 
2010). Bridges et al. (2010) went on to show that increasing the length of proestrus in 
ovulating follicles of the same size lead to increased estradiol concentration prior to TAI, 
increased progesterone concentrations of during the mid-luteal phase of the 
subsequent estrous cycle, and increased TAI pregnancy rates. Furthermore, at this point 
it was becoming evident that there was a negative relationship between the duration of 
dominance of the ovulating follicle and fertility (Bleach et al., 2004; Cerri et al. 2009) as 
highlighted originally by Townson et al. (2002) when he reported increased conception 
rates in 3 versus 2 wave cows. Thus, a more ideal protocol would both need to shorten 
dominance and increase time of proestrus. 
 Modifications of the 7-d CO-Synch protocol to increase length of proestrus to 
greater than 66 h proved unrewarding (Dobbins et al., 2006) due to increases in early 
estrus behavior prior to AI likely caused by increased size and maturity of the dominant 
follicle. Therefore, a novel approach was required to extend the proestrus phase and 
shorten dominance, without increasing the maturity of the dominant follicle. Bridges et 
al. (2008) speculated that a reduction in the interval from the initial injection of GnRH to 
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PGF2α administration and progestin withdrawal would result in elevated levels of 
estradiol and decrease the maturity of the ovulated follicle and thus increase TAI 
pregnancy rates. Comparison of the more recently developed 5 d and established 7-d 
CO-Synch + CIDR protocols resulted in similar TAI pregnancy rates when inseminated at 
60 h following PGF2α administration (Bridges et al., 2008). Bridges et al. (2008) further 
modified the new protocol and extend proestrus by increasing the time between PGF2α 
administration and TAI to 72 h resulting in increased pregnancy rates to TAI when 
compared to the existing 7-d CO-Synch + CIDR protocol; 80.0% vs 66.7% and 56.2% vs 
65.3% respectively.  
 The major drawback to the newly developed protocol was the induction of 
luteolysis in the accessory CL created with the initial GnRH injection. Since the interval 
from initial GnRH to PGF2α administration was only 5 d it was widely unknown whether 
luteolysis was achievable with a single 25 mg dose of PGF2α (Bridges et al., 2008). 
Therefore, in the initial design Bridges et al. (2008) used two separate 25 mg doses of 
PGF2α approximately 12 h apart. However, in vivo, PGF2α has been demonstrated to act 
in a pulsatile fashion approximately 6 to 8 h apart with variability in the duration and 
magnitude (Silvia et al., 1991). Therefore, when the efficacy of two separate 25 mg 
doses of PGF2α was shown to be required over a single 25 mg dose an interval of 
approximately 6 to 7 h was used between administrations of PGF2α (Kasimanickam et al., 
2009; Peterson et al., 2011). Therefore, based upon this research, the Beef 
Reproduction Task Force currently recommends an 8 h interval between PGF2α 
administrations (Johnson et al., 2013). 
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2.6.2 Modifications 
 While acceptable pregnancy rates have been reported with the 5dCO, the 
necessity of two separated doses of PGF2α leads to increased cost and handling times for 
producers. New research needed to be performed to make this protocol more 
convenient and applicable for producers in the field. One way to increase convenience 
was to consider decreasing number of trips through the chute by administration of two 
doses of PGF2α concurrently with CIDR removal. More recent work in heifers indicated 
that a single dose of PGF2α at CIDR removal was adequate to induce luteolysis in both 
diary (Rabaglino et al., 2010) and beef heifers (Cruppe et al., 2014; Kasimanickam et al., 
2014). Therefore, Bridges et al. (2012) speculated that since dairy heifers receive a 
higher PGF2α dose per body weight, by increasing the PGF2α dose or administering two 
25 mg PGF2α doses simultaneously the same results could be achieved in beef cattle. 
Bridges et al. (2012) went on to demonstrate that FTAI pregnancy rates and regression 
of the CL did not differ when two 25 mg doses of PGF2α were administered either 
simultaneously or 8 h apart. Furthermore, both methods proved more efficacious via 
FTAI pregnancy rates and CL regression than a single 25 mg dose of PGF2α. 
 More recently discussion has focused on the requirement or need for GnRH on 
the front end on the 5dCO. The fact remains that any estrous synchronization protocol 
that uses GnRH on the onset of the protocol, such as the 5dCO, only 66 to 70% of beef 
cows have been shown to respond to the initial injection of GnRH (Geary et al., 2000). 
The 5dCO was designed and initial studies showed no difference in estradiol 
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concentrations following PGF2α administration or follicle size at TAI when response to 
initial GnRH was compared (Bridges et al., 2014). Therefore, the question was raised if 
the initial administration of GnRH was required. In dairy heifers, Lima et al. (2011) was 
able to demonstrate that removal of the initial injection of GnRH resulted in no 
significant change in TAI pregnancy results. Similarly, Cruppe et al. (2014) found no 
difference in TAI pregnancy results when the initial injection of GnRH was eliminated in 
beef heifers. However, this data was contrasting to work done by Kasimanickam et al. 
(2014), who demonstrated that the initial injection of GnRH resulted in a significant, 8 % 
increase in TAI pregnancy results. Therefore, a conclusion cannot be made on the 
requirement of the initial GnRH within the 5dCO in beef heifers at this time. 
 Analysis of the requirement of the initial GnRH in the 5dCO in beef cows has 
been limited. Dias et al. (2014) studied the response to the initial GnRH and the effect of 
response to follicular growth, interval to estrus, and TAI pregnancy rates. Interestingly, 
although dominant follicle size at TAI and response to the second injection of GnRH was 
not affected by the response to the initial GnRH injection, TAI estrous response and 
pregnancy rates were significantly higher (p < 0.05) in the cows that did not respond 
(65.0 %) versus those that did respond (51.5%) to the initial injection of GnRH (Dias et 
al., 2014) in the 5dCO. Thus, suggesting that the requirement of the initial GnRH in the 
5dCO needs to be evaluated in beef cows.  
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2.7 Statement of the Problem 
 The continued development of artificial insemination and estrus synchronization 
strategies have allowed beef producers to integrate superior genetics. However, even 
though multiple options are available for implementation, reception and utilization 
within the United States remains at low levels within the beef sector (NAHMS, 2009). To 
improve adoption of estrus and ovulation synchronization protocols continued 
development and improvements of existing protocols as well as creation of new 
protocols needs to be performed with feasibility of the producer in mind. Therefore, 
modifications of existing protocols that reduce the number of hormonal interventions 
and/or frequency and duration of animal handling need to be evaluated. 
 Currently, research into the 5dCO has indicated that decreases in both hormonal 
intervention and frequency of animal handling can be achieved. Removal of the initial 
GnRH injection would not only decrease hormonal intervention, but in decrease 
handling time and eliminate extra costs to the producer. More specifically, effective 
response to the initial GnRH injection results in a young, accessory CL at CIDR removal 
that requires two doses of PGF2α. By removing the initial GnRH, the extra PGF2α dose is 
no longer required to induce CL regression. Therefore, increasing feasibility for the 
producer by eliminating extra handling time/frequency and additional costs for 
hormones. Increasing the feasibility of the 5dCO will hopefully facilitate increased 
adoption and utilization within beef producers in the United States. 
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 The overall goals of the experiments included in this thesis are to determine the 
impact when no GnRH is administered at CIDR insertion on ovarian parameters and FTAI 
pregnancy rates. From these goals, application of this modified protocol may be 
explored within the beef industry. In addition, increased convenience of the FTAI 
protocol may even further promote the implementation of AI programs in beef cattle. 
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CHAPTER 3 
OVARIAN FUNCTION IN BEEF COWS WHOSE OVULATION WAS SYNCHRONIZED USING 
THE 5-DAY CO-SYNCH + CIDR PROTOCOL WITH AND WITHOUT GNRH AT CIDR 
INSERTION 
 
3.1 Abstract 
 The objective of this experiment was to evaluate the effects of GnRH at 
controlled internal drug release (CIDR) insertion in the 5-d CO-Synch + CIDR protocol 
(5dCO) on ovarian follicular dynamics and circulating steroid hormone concentrations. 
Non-pregnant, non-lactating beef cows (n = 15) were used in a 3 x 3 Latin square design, 
with repetitions occurring every 21 d. Animals were assigned to treatment by age and 
BCS to receive either: 1) standard 5dCO hormone administration including 100 µg of 
GnRH at CIDR insertion and two concurrent 25-mg doses of prostaglandin F2α (PGF2α) 
delivered  at CIDR removal (G1-2PG), 2) no GnRH at CIDR insertion and two concurrent 
25-mg doses of PGF2α at CIDR removal (NoG1-2PG), or 3) no GnRH at CIDR insertion and 
a single 25 mg dose of PGF2α at CIDR removal (NoG1-1PG).   All cows were monitored for 
behavioral estrus for 72 h after CIDR removal at which time 100 µg of GnRH was 
administered.  Cows underwent transrectal ultrasonography to observe ovarian 
structures, and coccygeal blood samples were taken for subsequent progesterone and 
estradiol analyses at CIDR insertion, CIDR removal, final GnRH administration, and d 5 
and d 10 post PGF2α administration. An additional blood sample was collected on cows 
that displayed estrus between PGF2α and the second GnRH administration. Data were 
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analyzed using the MIXED and GLIMMIX procedures of SAS for the continuous and 
binary response variables, respectively. Dominant follicle diameter did not differ among 
treatments at CIDR removal or final GnRH (P ≥ 0.61). Percentage of animals whose 
corpus luteum (CL) regressed in response to PGF2α, estrus detection aid score, and CL 
volume 10 d following PGF2α administration did not differ among treatments (P ≥ 0.18). 
Post-ovulation plasma progesterone did not differ among treatments (P ≥ 0.29), and 
plasma estradiol was not different at CIDR removal or final GnRH administration (P ≥ 
0.59). However, peak plasma estradiol concentrations were greater (P = 0.01) in NoG1-
2PG than NoG1-1PG (5.85 and 2.93 ± 0.55 pg/mL, respectively), with G1-2PG being 
intermediate (3.31 ± 0.55 pg/mL). In conclusion, follicle and CL growth as well as 
subsequent progesterone concentrations were unaffected by removal of the initial 
GnRH in the 5dCO; however, inconsistency of estradiol concentrations merits 
implementation of a field trial to elucidate impacts of protocol modification on fertility. 
 
3.2 Introduction 
 To better facilitate the utilization of artificial insemination in beef cattle, several 
ovulation synchronization protocols have been developed to facilitate mass 
insemination of all females at a predetermined fixed time point [fixed timed artificial 
insemination (FTAI)]. The 5-d CO-Synch + controlled internal drug release (CIDR) 
protocol (5dCO) has proven efficacious and produces acceptable pregnancy rates 
following FTAI in beef and dairy cattle (Wilson et al., 2007; Bridges et al., 2008; Santos et 
al., 2010). The standard 5dCO involves insertion of a CIDR and administration of an 
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initial dose of gonadotropin releasing hormone (GnRH; G1) followed approximately 5 d 
later by CIDR removal and administration of two doses of prostaglandin F2α (PGF2α) 
approximately 8 h apart. Fixed timed artificial insemination with a second dose of GnRH 
(G2) occurs 72 h following removal of CIDR and PGF2α administration (Johnson et al., 
2013). 
 Recent work (Dias et al., 2014) has shown that failure of beef cows to respond to 
G1 in 5dCO has resulted in increased behavioral estrus and FTAI pregnancy rates. 
Although further research is needed to confirm this initial finding, the removal of G1 has 
been identified as a potential area of modification of 5dCO. If proven effective, the 
removal of G1 in 5dCO would be advantageous beyond pregnancy success. Removal of 
G1 would render the second 25-mg dose of PGF2α unnecessary because no corpus 
luteum (CL) younger than 5 d old would be present to regress. Furthermore, this 
protocol modification would be more cost-effective, potentially aiding in increased 
utilization of artificial insemination within the beef sector. Therefore, the objective of 
this study was to evaluate the effects of G1 removal from 5dCO on ovarian follicular 
dynamics, circulating preovulatory estradiol and postovulatory progesterone 
concentrations in postpartum beef cows. We hypothesized that removal of G1 from 
5dCO would have no detrimental effects upon ovarian parameters and steroid hormone 
concentrations in beef cows. 
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3.3 Material and Methods 
3.3.1 General 
 All protocols, procedures, and animal handling were conducted in a manner 
approved by the Iowa State University Institutional Animal Care and Use Committee. 
Research was conducted at Iowa State University Zumwalt Station Research Center in 
Ames, Iowa from March 2015 to May 2015. 
 
3.3.2 Animals and treatments 
Non-pregnant, non-lactating mature Angus and Angus-Simmental beef cows 
[n=15; age = 7.93 ± 0.13 yr; body condition score (BCS) = 4.8 ± 0.1 (1 = emaciated, 9 = 
obese, Wagner et al., 1988)] were used to study the effects of G1 removal in 5dCO on 
ovarian follicular dynamics and circulating steroid concentrations. Animals were 
stratified and allocated by age and BCS to a 3x3 Latin square design to receive either: 1) 
standard 5dCO including 100 µg of GnRH at CIDR insertion and two concurrent 25 mg 
doses of PGF2α delivered at CIDR removal (G1-2PG), 2) no GnRH at CIDR insertion and 
two concurrent 25 mg doses of PGF2α at CIDR removal (NoG1-2PG), or 3) no GnRH at 
CIDR insertion and a single 25 mg dose of PGF2α at CIDR removal (NoG1-1PG). All 
animals were given a 100-µg dose of GnRH 72 h after CIDR removal. All animals were 
housed throughout the treatment periods in a single grass lot with access to water and 
free choice hay and mineral supplement to minimize environmental and nutritional 
influences. 
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3.3.3 Performance characterization 
 Five d prior to initiation of treatments BCS were assessed; subsequent BCS were 
taken 5 d prior to initiation of each repetition of the Latin square. Body condition scores 
were the average of scores assessed by the same two trained investigators at each time 
point. Final BCS for each repetition was the equivalent to the BCS prior to starting the 
subsequent repetition. Final BCS was taken on d 16 of the final repetition. 
 
3.3.4 Experimental design 
The experimental design for the 3x3 Latin square is illustrated in Figure 3.1. On d 
0 a CIDR impregnated with 1.38 grams of progesterone (CIDR; Zoetis Animal Health, 
New York, NY) was placed in all cows. In addition to CIDR insertion on d 0, animals 
within treatment G1-2PG (n = 5) received 100 mg GnRH (Factrel; Zoetis Animal Health, 
New York, NY). After 5 d (d 5), all cows had CIDR removed, and an EstrotectTM heat 
detection aid (Rockway Inc., Spring Valley, WI) was placed on the tail head of each 
animal.  Also, based upon treatment, animals received either two concurrent 25 mg 
doses (G1-2PG and NoG1-2PG) or a single 25 mg dose (NoG1-1PG) of PGF2α (Lutalyse, 
Zoetis Animal Health, New York, NY). Animals were observed for 30 min at 0630 h and 
1700 h for behavioral estrus by trained personnel for 72 h following CIDR removal. 
Estrus detection aid activity was scored (1 = patch completely activated or > 50% 
activated; 2 = patch partially activated or between 25 and 50% activated with obvious 
signs of mounting; 3 = no signs of mounting, patch not activated or less than 25 %), and 
aid was removed at the time of behavioral estrus (aid score < 2 and visual confirmation 
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of behavioral estrus) if observed. The remaining animals had estrus detection aid 
activity recorded and aid was removed 3 d following CIDR removal and concurrent PGF2α 
administration (d 8). In addition, all animals received 100 mg GnRH on d 8 (72 h after 
CIDR removal and PGF2α administration). Repetitions 2 and 3 of the Latin square started 
on d 21, or 13 d following G2 of the preceding repetition. 
 
3.3.5 Ovarian characterization 
 All animals were subjected to transrectal ultrasonography (IbexTM Portable 
Ultrasound, variable MHz linear array transducer, E.I. Medical Imaging, Loveland, CO) for 
characterization of ovarian structures and ovulatory follicular wave. Ultrasound 
examinations were performed at approximately 0800 h by the same investigator 
throughout the experiment on d 0, 5, 8, 10, and 15. All antral follicles ≥ 7 mm in 
diameter had size and location recorded by drawing representative sketches of each 
ovary. All recorded follicles were measured using the caliper function of the ultrasound, 
and diameter of a given follicle was determined via the average of the greatest cross-
sectional perpendicular measurements. Dominant follicle was designated as the largest 
growing follicle of the cohort, and the secondary follicle was the second largest growing 
follicle within the same follicle cohort. Response to GnRH or resetting of the follicular 
wave was determined by the ovulation, loss of, or consistent decrease in size of the 
dominant follicle that existed at initiation of treatment. 
Corpora lutea locations were recorded in the same manner previously described 
for ovarian follicles. Total CL volume was calculated using the caliper function of the 
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ultrasound to determine cross-sectional perpendicular measurements and a formula for 
rotary ellipsoid V= 4/3 π ab2 (where a = longitudinal axis and b = transverse axis). If a 
lacuna was present, the volume of the lacuna was calculated via the rotary ellipsoid 
equation and its area was subtracted from the total CL volume to determine volume of 
total luteal tissue. 
 
3.3.6  Plasma steroid hormone analysis 
 Blood samples were collected throughout the experiment for evaluation of 
steroid hormone (estradiol 17-β and progesterone) concentrations. Blood samples were 
collected on day of CIDR insertion (d 0), day of CIDR removal (d 5), day of G2 
administration (d 8), and at three strategic time points to assess luteal tissue growth and 
function (d 10, d 12, and d 15). Furthermore, an additional blood sample was collected 
on any animal that displayed behavioral estrus between PGF2α and G2 administration (at 
time of such behavior was exhibited). Samples were collected via coccygeal 
venipuncture in 6 mL ethylenediaminetetraacetic acid (EDTA) vacutainer tubes (10.8 mg 
EDTA; BD VacutainerTM; Becton, Dickinson and Co., Franklin Lakes, NJ), inverted multiple 
times to mix, and immediately placed in ice. Samples were centrifuged at 1,750 x g for 
25 minutes at 4° C, and plasma was recovered into 5 mL polystyrene tubes and frozen at 
-20° C for subsequent hormone analyses.  
 Plasma samples obtained at CIDR insertion, G2 administration, and during 
presumed luteal growth (days 0, 8, 10, 12, and 15 respectively) were analyzed for 
progesterone concentrations to determine luteal tissue function. Serum concentrations 
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of progesterone were assayed via radioimmunoassay (RIA) with methods described by 
Engel et al. (2008). Average inter-assay CV was 15%, and average intra-assay CV was 
5.64%. Plasma collected at CIDR removal (d 5), G2 administration (d 8), and behavioral 
estrus (d 5-8) was analyzed for estradiol 17-β concentrations via RIA at South Dakota 
State University using the methodology described by Perry and Perry (2008). All 
estradiol 17-β concentrations were run in a single assay (intra-assay CV of 3.7%). Peak 
estradiol concentrations were the highest concentration of estradiol from either the 
plasma samples collected at behavioral estrus or G2 administration. 
 
3.3.7 Statistical analysis 
 Binomial data (follicular turnover at G1, CL regression, behavioral estrus, and 
ovulation of the dominant follicle) were analyzed using the GLIMMIX procedure of SAS 
9.3 (SAS Institute Inc., Cary, NC). The remaining performance (BCS) and ovarian 
parameters (dominant follicle size at CIDR removal, estrus detection aid score, dominant 
and secondary follicle size at ovulation, CL area, and steroid concentrations) were 
analyzed using the MIXED procedures of SAS 9.3. The final analytical or statistical model 
included the fixed effect of treatment, and individual animal served as the experimental 
unit. Steroid hormone concentration was analyzed on an individual basis due to interest 
in CL reaching functional status following treatment versus the intent of repeated 
measures. 
 An ancillary analysis was conducted within the treatment group G1-2PG on 
whether or not animals responded to G1 administration (fixed effect), individual animal 
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was the experimental unit. In addition, a second ancillary analysis was performed to 
evaluate follicular wave reset at time of G1 administration among all treatments, 
independent of G1 administration, as a fixed effect and individual animals as the 
experimental unit.  
 For all variables statistical significance was declared at P-value ≤ 0.05, and 
tendencies were identified at a P-value > 0.05 and ≤ 0.10. It should be noted that one 
animal from repetition 1 treatment 2 had a large hematoma on her right ovary, 
excluding her ovarian parameters from the dataset; however, performance and 
hormone data remained in the dataset and were included in the final analysis. 
Furthermore, in the instances of a double ovulation (n=2), only data collected from the 
largest follicle was included in the dataset and final analysis.  
 
3.4 Results 
3.4.1 Age and performance characteristics 
 Per the experimental design of the study, cow BCS and age did not differ at 
initiation of the treatments (P ≥ 0.85; Table 3.1). In addition, BCS did not differ at any 
time point during the study; change in BCS during repetition was not different among 
treatments at any time point (P ≥ 0.33). 
 
3.4.2 Ovarian parameters 
 Ovarian parameter data is displayed in Table 3.2. Dominant follicle diameter did 
not differ among treatments at either CIDR removal or final GnRH administration (P ≥ 
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0.61). The percentage of animals that regressed their CL in response to PGF2α did not 
differ among treatments (P = 0.18). The number of animals displaying behavioral estrus 
prior to G2 administration, estrus detection aid score, and interval to behavioral estrus 
did not differ among treatments (P ≥ 0.27). Ovulation prior to or in response to G2 was 
not different among treatments (P > 0.10). Furthermore, no differences were identified 
among treatments for CL volume following PGF2α administration (P = 0.99). 
 Ancillary analyses of response to G1 and resetting of follicular wave (data not 
shown) revealed no differences in follicular diameter, percentage of animals that 
regressed their CL in response to PGF2α, number of animals displaying behavioral estrus 
prior to G2 administration, estrus detection aid score, interval to behavioral estrus, 
ovulation response, or CL volume (P ≥ 0.18). 
 
3.4.3 Plasma steroid hormone analysis 
 Plasma progesterone concentrations did not differ among treatments at CIDR 
insertion, time of final GnRH administration, or post ovulation (P ≥ 0.34; Table 3.3). 
Plasma estradiol concentrations were not different at CIDR removal or G2 (P ≥ 0.59; 
Table 3.3). However, peak plasma estradiol concentrations were greater (P = 0.04) in 
NoG1-2PG than NoG1-1PG (3.50 and 2.14 ± 0.37 pg/mL, respectively), with G1-2PG 
concentrations being intermediate (2.71 ± 0.37 pg/mL). Furthermore, in samples 
collected at behavioral estrus, plasma estradiol concentrations were greater (P < 0.01) in 
NoG1-2PG than NoG1-1PG (5.85 and 2.93 ± 0.55 pg/mL, respectively), with G1-2PG 
being intermediate (3.31 ± 0.55 pg/mL). 
67 
 
 Plasma progesterone concentrations did not differ among animals within G1-2PG 
that either did or did not respond to G1 (P ≥ 0.34; data not shown). However, animals 
that did respond to G1 had greater (P < 0.03) plasma concentrations of progesterone at 
time of final GnRH administration than animals that did not respond to G1 (1.39 and 
0.79 ± 0.19 ng/mL, respectively), and the same was true on d 10 (1.70 and 0.74 ± 0.27 
ng/mL, respectively). Plasma estradiol concentrations were not different at CIDR 
removal, or at peak concentration (P ≥ 0.34; data not shown). However, plasma 
estradiol concentrations were greater on d 8, or at G2 administration, (P < 0.01) in 
animals that responded to G1 than in those that did not respond to G1 (3.10 and 1.31 ± 
0.40 pg/mL, respectively). 
 Plasma progesterone concentrations did not differ among animals that reset 
their follicular wave at time of CIDR insertion or did not reset their follicular wave at 
CIDR insertion at any time point prior to or at G2 (P ≥ 0.12; data not shown).  However, 
plasma progesterone differed on d 10 with animals that reset their follicular wave at 
CIDR insertion having greater (P = 0.04) progesterone concentrations than those that did 
not reset their follicular wave (1.22 and 0.83 ± 0.19 ng/mL, respectively; data not 
shown). Plasma progesterone concentrations did not differ at any time point following d 
12, 4 d after CIDR removal (P ≥ 0.77; data not shown). Plasma estradiol concentrations 
did not differ at any time point among animals that did and did not reset their follicular 
wave at CIDR insertion (P ≥ 0.16; data not shown).  
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3.5 Discussion 
3.5.1 General 
 Artificial insemination remains as an underutilized technology in beef cattle 
operations within the United States. According to the National Animal Health 
Monitoring System (NAHMS, 2009), only 10% of beef herds currently use artificial 
insemination. Modifications to existing AI protocols (to make them more user-friendly 
and more cost effective to implement) may allow for increased adoption of AI within the 
United States beef herd.  The objective of this experiment was to evaluate one such 
modification to assess its potential impact on ovarian follicular dynamics, circulating 
preovulatory estradiol concentrations and circulating progesterone concentrations in 
postpartum, non-lactating beef cows. 
 Although acceptable pregnancy rates can be achieved with the standard 5dCO, 
modifications to facilitate greater compliance among beef producers (by decreasing 
handling time or frequency of hormonal injections) may prove advantageous. More 
specifically, questions have been raised relative to the necessity of G1 and two separate 
PGF2α doses in 5dCO protocol. Previous work by Kasimanickam et al. (2009) 
demonstrated that use of a single 25 mg dose of PGF2α in 5dCO in beef cows resulted in 
decreased FTAI pregnancy results when compared to two 25 mg doses administered 7 h 
apart. In heifers, however, a single 25 mg dose of PGF2α was adequate to induce 
luteolysis, and similar pregnancy rates were achieved when compared to heifers 
receiving two 25 mg doses of PGF2α (Rabaglino et al., 2010; Cruppe et al., 2014; 
Kasimanickam et al., 2014). It was speculated that heifers had a better response to a 
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single dose of PGF2α due to increased mg/kg dosing. Yet, Bridges et al. (2012) showed 
that a single 50 mg dose of PGF2α was adequate to induce luteolysis and achieve 
statistically similar FTAI pregnancy rates in cows when compared to two 25 mg doses 8 h 
apart. 
 While PGF2α requirements have been definitively identified, the requirement of 
G1 in 5dCO has not been challenged to date. Gonadotropin releasing hormone is 
theoretically required to synchronize ovulatory follicular wave initiation; however, 
response rate of beef cows to GnRH is widely variable in both cycling and anestrus beef 
cows (Geary et al., 2000; Atkins et al., 2010a; Atkins et al. 2010b; Bridges et al., 2014). 
Failure of beef cows to respond to G1 resulted in reduced TAI pregnancy rates when 
using the 7-d CO-Synch protocol (Geary et al., 1998) and decreased estradiol and 
progesterone concentrations in the 7-d CO-Synch + CIDR protocol (Bridges et al., 2014). 
Failure to respond to G1 in the 7-d CO-Synch + CIDR protocol results in ovulation of 
smaller, presumably immature, dominant follicles (Atkins et al., 2010a; Atkins et al., 
2010b). These smaller follicles are expected to result in decreased pregnancy rates 
(Lamb et al., 2001; Vasconcelos et al., 2001; Perry et al., 2005) with increased late 
embryonic death and fetal loss (Perry et al., 2005). Alternatively, G1 response failure has 
also resulted in aged dominant follicles with hindered developmental competence and 
decreased steroidogenesis (Bridges et al., 2008). 
The 5dCO, however, was designed to better accommodate cows not responding 
to G1 by shortening the overall length of the protocol to create younger, more 
competent oocytes (when compared to the 7-d CO-Synch + CIDR protocol). 
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Furthermore, the design of 5dCO allows for a lengthened proestrus (compared with the 
7-d CO-Synch + CIDR protocol), which leads to increased estradiol concentrations and 
higher potential pregnancy rates (Bridges et al., 2008; Bridges et al., 2014). However, it 
remained unknown how animals would be affected within 5dCO when they did not 
respond to G1. Therefore, multiple studies were designed to determine the effects of 
G1 within 5dCO.  
When G1 was eliminated from 5dCO, no difference in FTAI pregnancy rates was 
demonstrated in dairy heifers (Lima et al., 2011; Kasimanickam et al., 2014). However, in 
beef heifers mixed results were demonstrated with either similar (Cruppe et al., 2014) 
or decreased (Kasimanickam et al., 2014) pregnancy rates when G1 was eliminated. 
When response to GnRH was studied in beef cows, Dias et al. (2014) demonstrated that 
lack of response to G1 resulted in increased estrus response and FTAI pregnancy rates 
when compared to females that responded to G1. Interestingly, dominant follicle size at 
FTAI and response to the second GnRH injection was not affected by response to G1 
(Dias et al., 2014). These results raised speculation as to the requirement of G1 within 
5dCO in mature beef cows. 
 
3.5.2 Ovarian parameters 
 Regardless of treatment in this study, no differences were identified among 
ovarian parameters. Bridges et al. (2014) speculated that animals responding to GnRH 
within 5dCO may have accelerated follicular growth rates when progesterone is 
removed. The increased growth rate should theoretically result in increased estradiol 
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concentrations when compared to animals not responding and potentially having 
persistent, over-matured follicles. In the current study, G1 administration was expected 
to result in increased follicle turnover and subsequent increased follicular growth when 
compared with treatments lacking G1. Interestingly, these differences were not 
identified and G1 administration did not result in follicular dynamic changes as expected 
by the Bridges et al. (2014) hypothesis. Furthermore, as would be expected, when no 
differences in follicular growth rates were identified among treatments, no differences 
in behavioral estrus were identified among treatments. 
Similar to Dias et al. (2014), no differences were identified in the present study in 
dominant follicle diameter at time of G2 administration or in ovulation rates either prior 
to or in response to G2 administration when treatment group G1-2PG was isolated and 
the effects of response to G1 were analyzed. However, unlike Dias et al. (2014), no 
differences were found for incidence of behavioral estrus, estrus detection aid score, or 
interval from CIDR removal to behavioral estrus within the same analysis. As previously 
stated, the differences in estrous response is hypothesized to be due to the accelerated 
growth rate and increased estradiol production of smaller diameter ovarian follicles 
after removal of progesterone due to response to G1 (Bridges et al., 2014). However, 
data from Dias et al. (2014) indicated the opposite, with animals not responding to 
GnRH displaying greater prevalence of behavioral estrus and decreased time from CIDR 
removal to behavioral estrus. This finding of Dias et al. (2014) is also in contrast to the 
results from this study where no differences were identified in any of those parameters. 
However, although estrus response rate remains open for debate, based upon the 
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results from this study and from Dias et al. (2014) it is evident that, on average, G1 
response does not affect ovulatory follicle characteristics.  
 Additional data analysis by whether or not cows reset their follicular wave at 
CIDR insertion revealed similar results to the first ancillary analysis; no differences 
among any ovarian parameters. These findings are not surprising considering that, even 
when G1 is used to initiate a new follicular wave, no differences in dominant follicular 
characteristics are found.  The findings within this ancillary analysis further support the 
theory that 5dCO was designed to accommodate animals that either maintained their 
dominant follicle at G1 administration or initiated a new follicular wave (Bridges et al., 
2008).  
 
3.5.3 Plasma steroid hormone analysis 
 It is interesting to note that while there were no differences in dominant follicle 
size, behavioral estrus or estrus detection aid score, peak estradiol concentrations were 
different among the treatment groups. Because there were no differences among 
treatments in ovarian follicular dynamics, it is difficult to identify the causative agent for 
the increased estradiol concentrations within the NoG1-2PG treatment group. A 
possible explanation for the difference in estradiol concentrations could be due to a 
numerically larger (but non-significant) proportion of cows within the NoG1-2PG group 
exhibiting behavioral estrus than either G1-2PG or NoG1-1PG treatments. 
Similarly, when data were analyzed based upon response to G1, estradiol 
concentrations were higher at G2 administration in animals responding to G1. This 
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finding is consistent with Bridges et al. (2014) theory that animals responding to G1 
would have increased estradiol concentrations due to increased follicular growth. 
However, the follicular data from the current study do not support this claim as no 
differences in follicular growth rates were identified. What is of interest is that, although 
not significant, a larger proportion of females not responding to G1 displayed behavioral 
estrus and had a decreased interval from CIDR removal to behavioral estrus. This finding 
contrasts Dias et al. (2014) where animals that did not respond to G1 had an increased 
proportion of females displaying behavioral estrus with a shortened interval from CIDR 
removal to behavioral estrus. Thus, the Dias et al. (2014) data would suggest that 
animals not responding to G1 would have increased estradiol concentrations. In both 
scenarios, however, the lack of differences in follicular dynamics only allows for 
speculation as to why differences in estradiol concentrations were identified.  Within 
this study, we hypothesize that animals that did not respond to G1 achieved peak 
estradiol concentration prior to G2 administration. Therefore, circulatory estradiol 
concentration was diminished at time of G2 administration.  
 Similar to the result seen by Bridges et al. (2014) plasma progesterone 
concentrations did not differ among treatments. Interestingly, when data were further 
analyzed based upon both response to G1 and initiation of a new follicular wave, 
animals that started a new wave at G1 had increased progesterone concentrations for 
up to 2 d following G2.  Although, initial progesterone concentrations were different up 
to 2 d following G2, all treatments reached concentrations at or above the 3.0 ng/ml 
threshold reported to be the normal range of females 6 d following ovulation (Adams et 
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al., 2008). Although no animals in the current study underwent FTAI, further research is 
warranted to determine if elevated progesterone concentrations following G2 
compromise pregnancy rates.  
 
3.5.4 Conclusion 
 The removal of G1 from 5dCO had no detrimental effects on ovarian function in 
mature beef cows in this study. Hormone profiles in cows not receiving G1 warrant 
further research. The factor(s) driving increased estradiol concentration in cows from 
the NoG1-2PG treatment need to be elucidated.  Furthermore, the need remains to 
repeat these treatments and collect fertility and pregnancy data to determine if greater 
estradiol concentrations impact fertility when G1 is eliminated from the 5-d CO-Synch + 
CIDR protocol.  
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Table 3.1. Effects of initial GnRH administration or removal in the 5-d CO-Synch + 
CIDR1 protocol on age and body condition scores in mature beef cows 
 Treatment2   
Item G1-2PG NoG1-2PG NoG1-1PG SEM3 P-Value 
Age, yr 7.93 7.93 7.93 0.79 1.00 
BCS4, initial 4.81 4.89 4.79 0.13 0.85 
BCS4, final 4.96 4.90 4.91 0.07 0.95 
BCS4, change 0.14 0.01 0.12 0.07 0.33 
1 Controlled internal drug release 
2 Treatments included either 1) the standard 5-d CO-Synch + CIDR protocol including 
100 µg of GnRH at CIDR insertion and two concurrent 25 mg doses of PGF2α delivered 
at CIDR removal (G1-2PG), 2) no GnRH at CIDR insertion and two concurrent 25 mg 
doses of PGF2α at CIDR removal (NoG1-2PG), or 3) no GnRH at CIDR insert and a single 
25 mg dose of PGF2α at CIDR removal (NoG1-1PG). 
3 n = 45  
4 BCS on scale of 1 to 9 (1= emaciated, 9= obese; Wagner et al, 1988). 
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Table 3.2. Effects of initial GnRH administration or removal in the 5-d CO-Synch + CIDR1 protocol on ovarian parameters in mature 
beef cows 
 Treatment2   
Item G1-2PG NoG1-2PG NoG1-1PG SEM3 P-Value 
Follicular diameter at CIDR removal, mm 11.2 11.2 10.5 0.62 0.61 
CL regression after PGF2α, % 57.1 40.0 40.0  0.18 
Estrus prior to G24, % 33.3 64.3 46.7  0.27 
Interval from CIDR removal to behavioral estrus, h 58.0 65.2 65.1 4.14 0.37 
Estrus detection aid score5 2.33 1.93 2.13 0.24 0.52 
Follicular diameter at G2, mm 13.9 14.3 14.5 0.54 0.74 
CL volume, mm3 5.66 5.78 5.75 0.74 0.99 
1 Controlled internal drug release 
2 Treatments included either 1) the standard 5-d CO-Synch + CIDR protocol including 100 µg of GnRH at CIDR insertion and two 
concurrent 25 mg doses of PGF2α delivered at CIDR removal (G1-2PG), 2) no GnRH at CIDR insertion and two concurrent, 25 mg 
doses of PGF2α at CIDR removal (NoG1-2PG), or 3) no GnRH at CIDR insertion and a single, 25 mg dose of PGF2α at CIDR removal 
(NoG1-1PG). 
3 n = 44 
4 Second GnRH administration that occurs at theoretical fixed timed artificial insemination. 
5 Estrus Detection Aids were scored as follows: 1 = patch completely activated or > 50% activated; 2 = patch partially activated or 
between 25 and 50% activated with obvious signs of mounting; 3 = no signs of mounting, patch not activated or less than 25% 
activated 
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Table 3.3. Effects of initial GnRH administration or removal in the 5-d CO-Synch + CIDR1 protocol on steroid hormone 
concentrations in mature beef cows 
 Treatment2   
Item G1-2PG NoG1-2PG NoG1-1PG SEM3 P-Value 
Progesterone, ng/ml      
Day      0 4.54 4.56 4.10 0.53 0.78 
Day      8 1.03 1.39 0.96 0.28 0.51 
Day    10 1.12 1.34 0.85 0.32 0.55 
Day    12 1.40 2.01 1.54 0.30 0.34 
Day    15 2.98 3.46 3.38 0.37 0.61 
Estradiol, pg/ml      
Day      5 0.55 0.59 0.51 0.11 0.87 
Day      8 2.03 2.22 1.71 0.36 0.59 
Behavioral estrus4 3.31ab 5.85a 2.93b 0.55 <0.01 
Peak E25 2.71ab 3.50a 2.14b 0.37 0.04 
1 Controlled internal drug release 
2 Treatments included either 1) the standard 5-d CO-Synch + CIDR protocol including 100 µg of GnRH at CIDR insertion and two 
concurrent 25 mg doses of PGF2α delivered at CIDR removal (G1-2PG), 2) no GnRH at CIDR insertion and two concurrent 25 mg 
doses of PGF2α at CIDR removal (NoG1-2PG), or 3) no GnRH at CIDR insertion and a single 25 mg dose of PGF2α at CIDR removal 
(NoG1-1PG). 
3 n = 45 
4 Time point between d 5 and d 8 when animals displayed behavioral estrus (n = 13). 
5 Peak estradiol concentrations were determined as the highest concentration of estradiol from either the plasma samples collected 
at behavioral estrus or second GnRH administration. 
6 Treatments with similar superscripts do not differ. 
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Figure 3.1. Experimental protocol describing GnRH and PGF2α treatments and data collection in mature beef cows for analysis of 
ovarian parameters and steroid hormone concentrations in the 5-d CO-Synch + Controlled Internal Drug Release (CIDR) protocol. 
1 Treatments included either 1) the standard 5-d CO-Synch + CIDR protocol including 100 µg of GnRH at CIDR insertion and two 
concurrent 25 mg doses of PGF2α delivered at CIDR removal (G1-2PG), 2) no GnRH at CIDR insertion and two concurrent, 25 mg 
doses of PGF2α at CIDR removal (NoG1-2PG), or 3) no GnRH at CIDR insertion and a single, 25 mg dose of PGF2α at CIDR removal 
(NoG1-1PG). 
2 Administration of 100 mg GnRH 
3 No administration of GnRH 
4 Two concurrent 25 mg doses of PGF2α 
5 One single 25 mg dose of PGF2α 
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CHAPTER 4 
EFFECT OF GNRH ADMINISTRATION AT THE ONSET OF THE 5 DAY CO-SYNCH + CIDR 
PROTOCOL IN SUCKLED BEEF COWS 
 
4.1 Abstract 
 The objective of this experiment was to evaluate whether or not GnRH 
administration at controlled internal drug release (CIDR) insertion is needed in the 5-d 
CO-Synch + CIDR protocol (5dCO). Postpartum suckled beef cows (n = 2159) from 11 
herds at 5 universities were assigned by age, body condition score (BCS), and days 
postpartum to receive either: 1) standard 5dCO hormone administration including 100 
µg of GnRH at CIDR insertion and two concurrent 25-mg doses of prostaglandin F2α 
(PGF2α) at CIDR removal (G1-2PG), 2) no GnRH at CIDR insertion and two concurrent 25-
mg doses of PGF2α at CIDR removal (NoG1-2PG), or 3) no GnRH at CIDR insertion and a 
single 25-mg dose of PGF2α at CIDR removal (NoG1-1PG).  Estrus response between 
PGF2α administration and fixed timed-AI (FTAI) was determined using estrus detection 
aids.  All cows underwent FTAI 72 h after CIDR removal, concurrent with administration 
of 100 µg of GnRH. Estrous cyclicity prior to synchronization of ovulation was 
determined using a combination of 2 blood samples collected 10 d apart in conjunction 
with estrus detection aids applied approximately 24 d prior to CIDR insertion. 
Transrectal ultrasonography was performed on a subset of cows (n = 130) in two herds 
at two locations at both CIDR insertion and removal to record ovarian structures, as well 
as 31 to 42 d after FTAI to test for pregnancy. Data were analyzed using the MIXED and 
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GLIMMIX procedures of SAS for continuous and binary response variables, 
respectively.  Herd nested within university was included as a random effect.  Total 
number of ovarian follicles and diameter of the two largest follicles at CIDR insertion 
were not different (P ≥ 0.34). However, the largest follicle at CIDR removal had greater 
(P = 0.02) diameter in NoG1-2PG than G1-2PG and NoG1-1PG (13.2, 11.5, and 12.1 ± 0.5 
mm, respectively). Though estrous response was not different (P = 0.99) prior to FTAI, 
detection aid activation was more advanced (P = 0.01) in NoG1-1PG than G1-2PG and 
NoG1-2PG. Pregnancy to FTAI did not differ (P = 0.66) among G1-2PG (55.4 %), NoG1-
2PG (52.8 %), and NoG1-1PG (50.5 %) treatments.  Cows exhibiting estrus prior to FTAI 
had greater (P < 0.001) FTAI pregnancy rates (58.1 %) than those not exhibiting estrus 
(39.3 %), and cows that were cyclic at synchronization initiation had greater (P < 0.001) 
FTAI pregnancy rates (53.6 %) than non-cyclic cows (37.1 %). In conclusion, FTAI 
pregnancy rates were not affected by removal of the initial GnRH in the 5-d CO-Synch + 
CIDR protocol.  
 
4.2 Introduction 
Follicular waves are synchronized at the start of fixed-timed artificial 
insemination (FTAI) protocols with the administration of gonadotropin releasing 
hormone (GnRH), concurrent with insertion of a controlled internal drug release (CIDR) 
device. However, the response rate of beef cows to a single GnRH injection is widely 
variable in both cycling and anestrous beef cows (Atkins et al., 2010a; Atkins et al. 
2010b; Bridges et al., 2014; Geary et al., 2000). Failure of beef cows to respond to GnRH 
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has been detrimental to FTAI pregnancy rates (Geary et al., 1998) and led to decreased 
estradiol and progesterone concentrations in the 7-d CO-Synch +CIDR protocol (Bridges 
et al., 2014).  
The 5-d CO-Synch + CIDR protocol (5dCO) was designed, in part, to theoretically 
better accommodate cows not responding to the initial GnRH administration (G1). 
Shortening the length of time from G1 to CIDR removal and concurrent prostaglandin 
F2α (PGF2α) administration is speculated to allow for a younger, more developmentally 
competent oocyte to be present at FTAI and to prevent over-maturation of ovulatory 
follicles (Bridges et al., 2008; Bridges et al., 2014). When Dias et al. (2014) studied beef 
cows’ response to G1 in 5dCO, failure of response to G1 administration increased 
estrous response and FTAI pregnancy rates when compared with females that did 
respond to G1. However, Cruppe et al. (2014) observed similar FTAI pregnancy rates in 
beef heifers regardless of G1 administration.  These conflicting reports have led to 
speculation concerning the necessity to administer G1 as part of 5dCO. Accordingly, the 
objective of this study was to evaluate whether or not G1 administration at CIDR 
insertion in the 5-d CO-Synch + CIDR protocol is necessary for lactating beef cows. We 
hypothesized that removal of G1 from the 5dCO would have no detrimental effects 
upon FTAI pregnancy rates in beef cows. 
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4.3 Materials and Methods 
4.3.1 General   
 All protocols, procedures, and animal handling were conducted in a manner 
approved by the Institutional Animal Care and Use Committee of each of five 
collaborating universities. Research involved in 11 herds across 5 states and was 
conducted from May 2015 to December 2015. 
 
4.3.2 Animals and treatments 
Non-pregnant, postpartum, lactating mature beef cows at 11 locations across 5 
universities [n = 2159; age = 5.18 ± 2.8 yr; body condition score (BCS) = 5.47 ± 0.76 (1 = 
emaciated, 9 = obese, Wagner et al., 1988)] were used to study the effects of G1 
removal in the 5-d CO-Synch + CIDR protocol on FTAI pregnancy rates. Animals were 
stratified and allocated within herd by age, BCS, and days postpartum and received 
either: 1) standard 5-d CO-Synch + CIDR protocol including 100 µg of GnRH at CIDR 
insertion and two concurrent 25-mg doses of PGF2α delivered at CIDR removal (G1-2PG), 
2) no GnRH at CIDR insertion and two concurrent 25-mg doses of PGF2α at CIDR removal 
(NoG1-2PG), or 3) no GnRH at CIDR insertion and a single 25-mg dose of PGF2α at CIDR 
removal (NoG1-1PG). All cows were bred via FTAI at 72 h after CIDR removal with 
concurrent GnRH (100 µg) administration.  
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4.3.3 Experimental design 
The experimental design is illustrated in Figure 4.1. Estrous detection aids 
(EstrotectTM heat detection aid; Rockway Inc., Spring Valley, WI) were placed on the tail 
head of each animal 32 d (d -32) prior to FTAI. Body condition scores were collected on 
animals 18 d (d -18) prior to FTAI. In addition, a coccygeal blood sample was taken in a 
subset of cows (n = 280) across 3 locations on d -18 to determine cyclicity. On d -8, 
estrous detection aids were removed and scores were assigned (1 = patch completely 
activated or > 50% activated; 2 = patch partially activated or between 25 and 50% 
activated with obvious signs of mounting; 3 = no signs of mounting, patch not activated 
or less than 25% activated) and cyclicity was determined (estrus detection aid score ≤ 2). 
An intravaginal device impregnated with 1.38 grams of progesterone (CIDR; Zoetis 
Animal Health, New York, NY) was placed in all cows (d -8), and the same subset of 
animals previously mentioned had a second coccygeal blood sample taken. 
Furthermore, animals within treatment G1-2PG were administered 100 µg GnRH 
(Factrel; Zoetis Animal Health, New York, NY) concurrent with CIDR insertion. After 5 d 
(d -3), all CIDRs were removed and, based upon treatment, animals received either two 
concurrent 25-mg doses (G1-2PG and NoG1-2PG) or a single 25-mg dose (NoG1-1PG) of 
PGF2α (Lutalyse, Zoetis Animal Health, New York, NY). New estrous detection aids were 
placed on the tailhead of each animal to monitor estrus activity for 72 h prior to FTAI. 
Fixed timed-AI occurred approximately 72 h (d 0) following CIDR removal and PGF2α 
administration. All animals received 100 µg GnRH concurrent with FTAI. Estrous 
detection aid score was recorded and signs of behavioral estrus determined (estrous 
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detection aid score ≤ 2) concurrent with FTAI. Pregnancy testing was performed via 
transrectal ultrasonography (IbexTM Portable Ultrasound, variable MHz linear array 
transducer, E.I. Medical Imaging, Loveland, CO) at 32 to 42 d after FTAI. At 42 d 
following the end of the breeding season, a second pregnancy test was performed to 
determine final end of season pregnancy rate. Pregnancy was confirmed when a viable 
fetus was identified. 
 
4.3.4  Plasma steroid hormone analysis 
 Coccygeal blood samples were collected on d -18 and d -8 on a subset of animals 
at three locations (n = 280) for assessment of progesterone concentration and pre-
synchronization cyclicity status. Samples were collected in 6 mL 
ethylenediaminetetraacetic (EDTA) vacutainer tubes (10.8 mg EDTA; BD VacutainerTM; 
Becton, Dickinson and Co., Franklin Lakes, NJ), inverted multiple times, and immediately 
placed in ice. Samples were centrifuged at 1,750 x g for 25 minutes at 4° C and plasma 
was recovered into 5 mL polystyrene tubes and frozen at -20° C for subsequent analysis. 
 Plasma samples were analyzed for progesterone concentrations to determine 
luteal tissue function and thus cyclicity status. Plasma concentrations of progesterone 
were analyzed with radioimmunoassay (RIA) via methods described by Engel et al. 
(2008). The average inter-assay CV was 15%, and the intra-assay CV was 5.64%. Animals 
were determined to be cyclic if a single sample contained a progesterone concentration 
≥ 1.0 ng/ml. 
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4.3.5 Ovarian characterization 
 A subset of animals (n = 130) at two herds, across two locations underwent 
transrectal ultrasonography for characterization of ovarian structures during the 
ovulatory follicular wave. Ultrasound examinations were performed by trained 
investigators at each location on days -8 and -3. Diameter and location of follicles ≥ 7 
mm in diameter were recorded by drawing representative sketches of each ovary. These 
follicles were measured using the caliper function of the ultrasound, and diameter was 
determined as the average of the greatest cross-sectional perpendicular measurements. 
The largest follicle of the cohort was declared as the dominant follicle, and the 
secondary follicle was the second largest growing follicle within the same cohort. Corpus 
luteum (CL) size and location were recorded in the same manner as antral follicles. 
Response to GnRH (resetting of the follicular wave) was determined by the presence of 
a new CL on d -3 of the protocol (time of CIDR removal). 
 
4.3.6 Statistical analysis 
 Binomial response variables (cyclicity, follicular turnover at G1, behavioral 
estrus, FTAI pregnancy rate, end of breeding season pregnancy rate and within 
treatment [response to G1]) were analyzed using the GLIMMIX procedure of SAS 9.3 
(SAS Institute Inc., Cary, NC). The remaining performance (BCS) and ovarian parameters 
(dominant and secondary follicle size at CIDR insertion, estrous detection aid score, 
dominant and secondary follicle size at CIDR removal, and steroid concentrations) were 
analyzed using the MIXED procedures of SAS 9.3. The final model included the fixed 
86 
 
effect of treatment and herd nested within university as a random effect; individual 
animal served as the experimental unit. 
 A first ancillary analysis of all variables was performed to analyze response to G1 
administration within the G1-2PG treatment group. Response to G1 was used as a fixed 
effect, with herd nested within university as a random effect; individual animal was the 
experimental unit. A second ancillary analysis was performed to evaluate follicular wave 
reset at time of CIDR insertion among all treatments, independent of G1 administration. 
Follicular wave turnover at d -8 was used as a fixed effect, with herd nested within 
university as a random effect; individual animals was the experimental unit.  
 Significance was declared at P-value ≤ 0.05, and tendencies were identified at a 
P-value > 0.05 and ≤ 0.10 for all variables. Cyclicity status prior to synchronization 
protocol implementation from one university (multiple herds) was excluded from 
cyclicity data due to lack of coccygeal blood samples or estrous detection aid scores. 
Furthermore, any animal that lost estrous detection aid patch prior to being scored or 
did not have coccygeal blood samples taken was excluded from the corresponding 
cyclicity or behavioral estrus data sets (n = 589). 
 
4.4 Results 
4.4.1 Age and performance characteristics 
 Per the experimental design of the study, cow age, BCS, and days postpartum did 
not differ at initiation of the treatments (P ≥ 0.48; Table 4.1). Furthermore, ancillary 
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analysis yielded no differences in age, BCS, and days postpartum between treatment 
groups studied (P ≥ 0.20; data not shown). 
 
4.4.2 Ovarian parameters 
 The percentage of animals that displayed behavioral estrus prior to treatment 
initiation (d -8; Fig. 4.1) did not differ among treatment groups (P ≥ 0.85; Table 4.1). 
Diameter of the two largest ovarian follicles did not differ across treatments at CIDR 
insertion (P ≥ 0.33; Table 4.3). In addition, diameter of the second largest follicle was 
similar among treatments (P ≥ 0.16; Table 4.3) at CIDR removal (d -3; Fig. 4.1). However, 
the diameter of the largest follicle on d -3 (CIDR removal) was greater (P = 0.02; Table 
4.3) in NoG1-2PG than in both G1-2PG and NoG1-1PG (13.2, 11.5, and 12.1 ± 0.5 mm, 
respectively). The percentage of animals displaying behavioral estrus prior to FTAI did 
not differ among treatments (P = 1.00; Table 4.2). Intriguingly, estrous detection aid 
score (activation) was more advanced (lower; P = 0.01; Table 4.2) in NoG1-1PG than in 
G1-2PG and NoG1-2PG (1.49, 2.13, and 1.89 ± 0.32, respectively). Yet, FTAI pregnancy 
rate were not different (P = 0.66; Table 4.2) among treatment groups.  
 Ancillary analysis of response to G1 in a subset of animals revealed no 
differences in estrous detection aid scores or animals that displayed behavioral estrus 
prior to treatment (P ≥ 0.35; data not shown). Diameter of the two largest ovarian 
follicles on d -8 was not different between response groups (P ≥ 0.30; data not shown). 
However, the diameter of the dominant follicle and second largest follicle at CIDR 
removal (d-3) was greater (P ≤ 0.01) in animals that did not respond to G1 than in those 
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that did (12.9 vs 9.6 ± 0.6 mm; and 9.5 vs 7.9 ± 0.5 mm, respectively; data not shown). 
Similarly, animals failing to respond to G1 tended (P = 0.10) to have an increased 
percentage of animals displaying behavioral estrus prior to FTAI when compared with 
animals that did respond (66.7 % vs 40.9 %, respectively; data not shown). 
Further ancillary analysis of follicular wave reset at d -8 showed no differences (P 
≥ 0.18) in animals that displayed behavioral estrus prior to treatment or diameter of the 
two largest follicles at CIDR insertion (data not shown). However, the diameter of the 
dominant follicle and second largest follicles at CIDR removal (d-3) were greater (P ≤ 
0.01) in animals that did not reset their follicular wave at d -8 than in those that did 
(13.3 vs 10.4 ± 0.4 mm, respectively; and 10.0 vs 8.3 ± 0.5 mm, respectively; data not 
shown). Furthermore, animals that did not reset the follicular wave at CIDR insertion 
had lower (more advanced) estrous detection aid scores (P ≤ 0.01; 1.4 vs 1.9 ± 0.3, 
respectively; data not shown) and an increased (P = 0.02) percentage of animals 
displaying behavioral estrus prior to FTAI (75.8 % vs 52.5 %, respectively; data not 
shown) than animals that did reset their follicular wave. 
 
4.4.3 Fixed timed artificial insemination pregnancy results 
 Fixed time artificial insemination pregnancy rates were affected by cyclicity prior 
to treatment (P < 0.001) and by signs of behavioral estrus prior to FTAI (P < 0.001). 
Animals that were cyclic at initiation of the synchronization protocol had greater FTAI 
pregnancy rates than non-cyclic animals (53.6 % vs 37.1 %, respectively; data not 
shown). In addition, animals that displayed signs of behavioral estrus prior to FTAI had 
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greater FTAI pregnancy rates than those animals that did not (58.1 % vs 39.3 %, 
respectively; data not shown). However, pregnancy to FTAI did not differ (P = 0.66; 
Table 4.2) among G1-2PG (55.4 %), NoG1-2PG (52.8 %), and NoG1-1PG (50.5 %) 
treatments. Furthermore, no differences were identified in FTAI pregnancy rates upon 
further ancillary analysis of G1 response (P = 0.35; data not shown) or follicular wave 
reset (P = 0.65; data not shown).  
 
4.5 Discussion 
4.5.1 General 
Artificial insemination of beef cattle within the United States remains an 
underutilized technology. Less than 10% of beef herds in the United States currently use 
artificial insemination as a way to increase the genetic value of the offspring produced 
(NAHMS, 2009). In an effort to increase utilization rates, synchronization protocols have 
been developed to make artificial insemination more labor efficient. Specifically, FTAI 
protocols that synchronize ovulation allow mass insemination of beef females. The 
5dCO is such a synchronization of ovulation protocol that has proven efficacious and 
produces acceptable pregnancy rates following FTAI in beef and dairy cattle (Bridges et 
al., 2008; Santos et al., 2010; Wilson et al., 2007). The standard 5dCO involves insertion 
of a CIDR and concurrent administration of an initial dose of GnRH followed 
approximately 5 d later by CIDR removal and administration of two doses of PGF2α 8 h 
apart. Fixed timed-AI accompanied by a second dose of GnRH occurs 72 h following 
removal of CIDR and PGF2α administration (Johnson et al., 2013). 
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 The drive to increase utilization of FTAI protocols has led to research on 
modifications of the 5dCO to decrease frequency of cow handling, number of hormone 
administrations, or both. Specifically, administration of two PGF2α doses 8 h apart has 
been a recent focus. Previously, Kasimanickam et al. (2009) demonstrated that two 
separate, 25-mg doses administered 7 h apart in beef cows resulted in increased FTAI 
pregnancy rates when compared to a single 25-mg dose in the 5dCO. However, when 
the same comparison was made in heifers, a single 25-mg dose of PGF2α was adequate 
to induce luteolysis and yield similar FTAI pregnancy rates as two separate 25-mg doses 
of PGF2α (Rabaglino et al., 2010; Cruppe et al., 2014; Kasimanickam et al., 2014). The 
difference in response rates of a single, 25-mg dose of PGF2α from cows to heifers was 
speculated to result from differences in mg per kg of BW dosing. This hypothesis was 
bolstered by Bridges et al. (2012) who demonstrated that two concurrent 25 mg (50 mg 
total) doses of PGF2α was adequate to induce luteolysis of all CL in beef cows and 
produce similar FTAI pregnancy rates. 
 Similar to questions regarding PGF2α, the administration of GnRH recently has 
been challenged within 5dCO. Failure of response to G1 led to detrimental effects upon 
FTAI pregnancy rates within the 7-d CO-Synch + CIDR protocol (Geary et al., 1998). 
Animals that failed to respond to G1 ovulated smaller, more immature dominant 
follicles (Atkins et al., 2010a; Atkins et al., 2010b) and cows exhibited decreased 
estradiol and progesterone concentrations (Bridges et al., 2014). These smaller 
dominant follicles impede pregnancy rates (Lamb et al., 2001; Vasconcelos et al., 2001; 
Perry et al., 2005) and increase late embryonic death and early fetal loss (Perry et al., 
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2005). Furthermore, another effect seen in follicles that do not respond to G1 is 
increased likelihood to become persistent follicles prior to FTAI (Bridges et al., 2008).  
 The design of 5dCO decreases the time interval from G1 to FTAI to create a 
younger more developmentally competent oocyte when compared with the 7-d CO-
Synch + CIDR protocol (Bridges et al., 2008; Bridges et al., 2014). However, the 
consequence of failing to respond to G1 on FTAI pregnancy rates within 5dCO remained 
unknown. Studies were developed in heifers that tested the elimination of G1 to mimic 
the effects of G1 response failure within 5dCO. No difference in FTAI pregnancy rates 
was observed in dairy heifers between animals that received or did not receive G1 (Lima 
et al., 2011; Kasimanickam et al., 2014). However, when the same hypothesis was tested 
in beef heifers, contrasting results were reported (Cruppe et al., 2014; Kasimanickam et 
al., 2014). Similar pregnancy rates were reported among animals receiving or not 
receiving G1 by Cruppe et al. (2014). Kasimanickam et al. (2014) however, reported 
decreased pregnancy rates in beef heifers when G1 was eliminated from the 5dCO. 
To date, only one study has analyzed failure of response to G1 within the 5dCO 
in beef cows. Dias et al. (2014) demonstrated that failure of beef cows to respond to G1, 
or the lack of a new CL at CIDR removal within the 5dCO, resulted in increased estrous 
response and FTAI pregnancy rates when compared with females that responded to G1. 
Intriguingly, dominant follicle size at FTAI and response to G2 was not affected by 
response to G1 (Dias et al., 2014). Therefore, failure of beef animals to respond to G1 
caused either similar or an increase in FTAI pregnancy rates (Cruppe et al., 2014; Dias et 
al., 2014). The actual need for G1 has been questioned.   
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The elimination of G1 from the standard 5dCO could prove advantageous. Not 
only would removing G1 at the onset of the protocol reduce the amount of pituitary 
hormone analog required, but also it would eliminate the second 25-mg dose of PGF2α, 
as there would not be a 5-d old accessory CL to lyse (Bridges et al., 2008; Kasimanickam 
et al., 2009). Therefore, removal of G1 would also allow for a more user friendly and 
lower cost protocol that could potentially facilitate increased utilization of artificial 
insemination technology within the beef sector. 
 
4.5.2 Ovarian parameters 
 In the present study no differences were identified in cyclicity status or ovarian 
parameters at CIDR insertion among treatment groups. However, upon CIDR removal, 
diameter of the largest ovarian follicle differed among treatments with NoG1-2PG 
having a larger dominant follicle than either G1-2PG or NoG1-1PG. Oddly, these data did 
not correlate to increased estrous aid activation or an increased percentage of females 
displaying estrous behavior. Instead, estrous detection aid score indicated increased 
activation in the NoG1-1PG treatment group versus both the G1-2PG and NoG1-2PG 
treatment groups. This is in contrast to data published by Perry et al. (2005) and Jinks et 
al. (2012) that indicated larger dominant follicles, upon induced ovulation, have 
increased estradiol concentrations and should lead to increased behavioral estrus. Thus, 
it is speculated that the larger dominant follicles within the NoG1-2PG treatment group 
may have become persistent with diminished steroidogenesis, while follicles of NoG1-
1PG cows potentially had more developmentally competent oocytes with potentially 
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increased growth and steroidogenesis during the proestrus period (Bridges et al., 2008; 
Bridges et al., 2014).  
 Interestingly, initial ancillary analysis of response to G1 within the G1-2PG 
treatment group showed similar results to those noted in the full dataset. Animals not 
responding to G1 had larger dominant follicles and larger secondary follicles at time of 
CIDR removal than those animals that did respond to G1. However, in this comparison 
the increased follicular size did correspond to a tendency for animals not responding to 
G1 to have increased behavioral estrus prior to G2 administration. This finding is similar 
to Dias et al. (2014) who reported increased behavioral estrus in animals failing to 
respond to G1 when compared with animals that did respond. Of interest, however, is 
that this response is not observed when animals are not administered G1 (i.e., in NoG1-
2PG and NoG1-1PG treatments). This highlights that some animals within the NoG1-2PG 
and NoG1-1PG groups may potentially have benefitted from G1 administration.  
Similar to the data just discussed, when the effect of follicular wave reset at CIDR 
insertion was analyzed, increased follicular diameter was seen in the two largest follicles 
at CIDR removal of animals that did not reset their follicular wave compared to animals 
that did reset their wave. Furthermore, the animals that did not reset their follicular 
wave at CIDR insertion had more advanced estrous detection aid scores with an 
increased percentage of females also displaying behavioral estrus. The results for the 
two ancillary analyses presented within this section are more in line with what would be 
expected from data reported by Perry et al. (2005) and Jinks et al. (2012). Although 
suspected advantages in ovulatory follicle size are shown from failure to reset the 
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follicular wave, the ability to identify these animals in an efficient and economical 
manner at protocol initiation remains elusive. Therefore, further research is warranted 
to develop an affordable chute-side test to determine G1 response or potential for 
follicular wave turnover. 
 
4.5.3 Pregnancy results 
 Considering that the 5-d CO-Synch + CIDR protocol was designed to 
accommodate animals that either maintained their dominant follicle or initiated a new 
follicular wave at G1 administration (Bridges et al., 2008), it is not surprising to some 
that no differences in pregnancy rates were identified among treatment groups in the 
present study. However, slight numerical differences were identified, likely due to 
differences in stage of estrous cycle of females within each treatment group. It is 
probable that a small number of animals in the NoG1-2PG and NoG1-1PG treatment 
groups would have benefitted from G1 administration or, in the case of the NoG1-1PG 
treatment group, two concurrent doses of PGF2α. Differences in follicular dynamics were 
identified in the subset of cows, but this did not affect FTAI pregnancy rates. Although 
NoG1-2PG had larger dominant follicles at CIDR removal and NoG1-1PG had more 
advanced estrous detection aid scores, neither proved advantageous when pregnancy 
rates were compared. Between these findings and the numerical differences in 
pregnancy rates, we are left to speculate if timing of estrus was affected by treatment. 
The timing of FTAI within this 5dCO was designed to align with animals that responded 
to G1. When G1 was not administered, we speculate that these animals may have 
95 
 
potentially entered behavioral estrus sooner due to larger and more estrogenic follicles 
at CIDR removal. Thus, a potential benefit may be had from a shortened window from 
CIDR removal to FTAI within animals that did not receive G1.  Further research is 
warranted in this area. 
In addition to altering timing of FTAI, a second potential for disconnect, and 
failure of increased estrus response in the NoG1-1PG to result in advantageous FTAI 
pregnancy rates, may lie in the relatively small subset of cows (n = 130) that were 
sampled for ovarian parameter assessment. The animals sampled were only within two 
locations, which makes it difficult to extrapolate across the entire data set. Thus, a need 
remains to investigate timing of estrus within treatment groups not receiving G1, and an 
expansion in the sample size of animals analyzed for ovarian dynamics. 
The same disconnect noted in regard to follicle diameter and estrus correlation 
was also identified within the ancillary analyses. The results are in contrast to widely 
held knowledge that increases in behavioral estrus rates will lead to increased 
pregnancy rates. This fact was proven within our own data set, as FTAI pregnancy rates 
were affected by signs of behavioral estrus.  Once again, the disconnect may stem from 
different timing of estrus between groups or the relatively small sample size studied for 
ovarian parameters within this study. 
 
4.5.4 Conclusion 
 The removal of G1 from the 5-d CO-Synch + CIDR protocol has no detrimental 
effects on pregnancy rates in mature lactating beef cows. However, differences in 
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ovarian follicular dynamics warrant further research in both scale and intensity to 
determine the factors driving disconnect between follicle diameter, behavioral estrous 
response and FTAI pregnancy rates. Furthermore, the development of a practical chute-
side test to determine follicular wave stage and expected response to G1 may prove 
beneficial to synchronization of ovulation protocols that potentially increase FTAI 
pregnancy rates.  
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Table 4.1. Production characteristics of lactating beef cows stratified by treatment 
 Treatment1   
Item G1-2PG NoG1-2PG NoG1-1PG SEM2 P-Value 
Age, yr 4.71 4.71 4.76 0.32 0.93 
BCS3 5.51 5.55 5.56 0.21 0.48 
Days Postpartum, d 71.3 71.9 71.4 2.61 0.88 
Cyclic, % 87.2 85.1 86.3  0.85 
1 Treatments included either 1) the standard 5-d CO-Synch + controlled internal drug 
release (CIDR) protocol including 100 µg of GnRH at CIDR insertion and two concurrent 
25 mg doses of PGF2α delivered at CIDR removal (G1-2PG), 2) no GnRH at CIDR insertion 
and two concurrent 25 mg doses of PGF2α at CIDR removal (NoG1-2PG), or 3) no GnRH 
at CIDR insertion and a single 25 mg dose of PGF2α at CIDR removal (NoG1-1PG). 
2 n = 2159  
3 BCS on scale of 1 to 9 (1= emaciated, 9= obese; Wagner et al, 1988). 
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Table 4.2. Effects of initial GnRH administration or removal in the 5-d CO-Synch + CIDR1 protocol on activation of estrus 
detection aid, behavioral estrus and FTAI2 pregnancy rates in lactating beef cows 
 Treatment2   
Item G1-2PG NoG1-2PG NoG1-1PG SEM3 P-Value6 
Patch score4 at FTAI5  2.13b 1.89b 1.49a 0.32 0.01 
Behavioral estrus, % 73.8 73.8 71.7  1.00 
FTAI pregnancy status, % 55.4 52.8 50.5  0.66 
1 Controlled internal drug release 
2 Treatments included either 1) the standard 5-d CO-Synch + CIDR protocol including 100 µg of GnRH at CIDR insertion and two 
concurrent 25 mg doses of PGF2α delivered at CIDR removal (G1-2PG), 2) no GnRH at CIDR insertion and two concurrent 25 mg 
doses of PGF2α at CIDR removal (NoG1-2PG), or 3) no GnRH at CIDR insertion and a single 25 mg dose of PGF2α at CIDR removal 
(NoG1-1PG).  
3 n = 2159  
4 Scored on a scale of 1 to 3 (1 = patch completely activated or > 50% activated; 2 = patch partially activated or between 25 and 50% 
activated with obvious signs of mounting; 3 = no signs of mounting, patch not activated or less than 25% activated). 
5 Fixed-timed artificial insemination 
6 Treatments with similar superscripts do not differ.   
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Table 4.3. Effects of initial GnRH administration or removal in the 5-d CO-Synch + CIDR1 protocol on ovarian parameters in 
lactating beef cows 
 Treatment2  
Item G1-2PG NoG1-
2PG 
NoG1-1PG SEM3 P-Value4 
Dominant follicle diameter at CIDR insertion, mm 13.1 12.1 12.6 0.85 0.34 
2nd Largest follicle diameter at CIDR insertion, mm 8.65 8.44 8.90 1.03 0.73 
Dominant follicle diameter at CIDR removal, mm 11.5b 13.2a 12.1b 0.54 0.02 
2nd Largest follicle diameter at CIDR removal, mm 8.75 10.2 9.08 0.63 0.16 
1 Controlled internal drug release 
2 Treatments included either 1) the standard 5-d CO-Synch + CIDR protocol including 100 µg of GnRH at CIDR insertion and two 
concurrent 25 mg doses of PGF2α delivered at CIDR removal (G1-2PG), 2) no GnRH at CIDR insertion and two concurrent 25 mg 
doses of PGF2α at CIDR removal (NoG1-2PG), or 3) no GnRH at CIDR insertion and a single 25 mg dose of PGF2α at CIDR removal 
(NoG1-1PG). 
3 n = 130  
4 Treatments with similar superscripts do not differ.  
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Figure 4.1. Experimental protocol describing GnRH and PGF2α treatments and data collection in lactating beef cows for analysis of 
fixed-timed artificial insemination (FTAI) pregnancy rates in the 5-d CO-Synch + Controlled Internal Drug Release (CIDR) protocol. 
1 Treatments included either 1) the standard 5-d CO-Synch + CIDR protocol including 100 µg of GnRH at CIDR insertion and two 
concurrent 25 mg doses of PGF2α delivered at CIDR removal (G1-2PG), 2) no GnRH at CIDR insertion and two concurrent 25 mg 
doses of PGF2α at CIDR removal (NoG1-2PG), or 3) no GnRH at CIDR insertion and a single 25 mg dose of PGF2α at CIDR removal 
(NoG1-1PG). 
2 Administration of 100 mg GnRH 
3 No administration of GnRH 
4 Two concurrent 25 mg doses of PGF2α 
5 One single 25 mg dose of PGF2α 
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CHAPTER 5 
GENERAL DISCUSSION 
 
 Modifications to existing fixed timed artificial insemination (FTAI) protocols may 
lead to increased utilization of artificial insemination (AI) within the beef sector of the 
United States. Currently, at approximately 10%, AI remains an underutilized technology 
for the advancement of genetics within the United States beef herd (NAHMS, 2009). 
Modifications to current ovulation synchronization protocols to make them easier, less 
labor intensive, and more cost effective to implement, may allow for increased 
implementation and use. The 5-d CO-Synch + controlled internal drug release (CIDR) 
protocol (5dCO) is an intensive FTAI protocol that through modifications may become 
more utilized by beef producers. The standard 5dCO begins with the insertion of a CIDR 
and concurrent administration of an initial dose of GnRH (G1) followed by CIDR removal 
and concurrent injection of prostaglandin F2α (PGF2α) 5 d later. Approximately 8 h 
following CIDR removal a second dose of PGF2α is administered with FTAI and another 
GnRH (G2) injection occurring approximately 72 h following (Johnson et al., 2013). 
 Two separate parts of the 5dCO have been highlighted as potential areas where 
modifications can be made to decrease cost, and potentially labor. The requirement of 
G1 and the need for two separate, 25-mg doses of PGF2α have specifically been 
identified as areas of potential modification. Bridges et al. (2012) studied the 
requirement of two separate, 25-mg doses of PGF2α 8 h apart by replacing it with two 
concurrent 25-mg doses of PGF2α. Results showed similar FTAI pregnancy rates in cows 
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when compared to those whom received two, separate 25, mg doses of PGF2α 
approximately 8 h apart. However, the second point of emphasis, the requirement of 
G1, has remained more perplexing in beef animals. Kasimanickam et al. (2014) reported 
decreased FTAI pregnancy rates in beef heifers when G1 was removed from the 
standard 5dCO. Yet, Cruppe et al. (2014) reported no differences in FTAI pregnancy 
rates when heifers either received G1 or were not administered G1. While the effect of 
removing G1 in beef heifers has delivered inconsistent results, the requirement of G1 in 
the 5dCO has not previously been studied intensively in beef cows. Dias et al. (2014) 
demonstrated that G1 may not be needed in cows when specifically evaluating the 
response to G1 in a 5-d CO-Synch + CIDR protocol. This was shown by beef cows that did 
not respond to G1 had increased behavioral estrus response and greater FTAI pregnancy 
rates. The experiments conducted in this thesis were designed to determine the effect 
of G1 removal from the 5dCO and evaluate effects on ovarian parameters and FTAI 
pregnancy rates. 
 The first experiment was designed to study the effects of the removal of G1 
during a 5dCO on ovarian parameters and steroid hormone concentrations. As reported 
in Chapter 3, removal of G1 from the 5dCO had no effect on follicle size at any time 
point within the study. In addition, no differences were identified in proportion of cows 
displaying behavioral estrus, interval to behavioral estrus, or ovulation rates to G2. 
Interestingly, despite the absence of differences in dominant follicle size or behavioral 
estrus, NoG1-2PG demonstrated greater peak plasma estradiol concentrations.  
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Previously, Dias et al. (2014) reported that failure to respond to G1 and not 
producing an accessory corpus luteum (CL) resulted in an increased proportion of 
females displaying behavioral estrus prior to FTAI, as well as a shortened interval to 
estrus. However, the data presented in Chapter 3 contrasted those findings as no 
differences were identified in the ancillary analysis when response to G1 was evaluated 
as the main effect. Yet, similar to Dias et al. (2014), no differences were identified in 
dominant follicle size at FTAI when response to G1 was the main effect. Lastly, it should 
be noted that like the intensive study, steroid hormone concentrations (more 
specifically estradiol) were significantly different even when no differences were 
identified in dominant follicle or CL size. It is speculated that the elevation in estradiol 
concentrations in those animals responding to G1 versus those that did not may be due 
to females whom did not respond to GnRH displaying behavioral estrus sooner and thus 
having decreasing concentrations of estradiol at theoretical FTAI. Furthermore, it must 
also be mentioned that the females not responding to G1 may have developed more 
persistent follicles. Therefore, these more mature follicles may produce less estradiol, as 
hypothesized by Bridges et al. (2008). 
Further ancillary analysis of the first experiment, Chapter 3, found few 
differences between animals that either did or did not reset their follicular wave upon 
initiation of the treatment protocol. The only identifiable difference was an increase in 
plasma progesterone concentrations for those animals that reset their follicular wave 2 
days following theoretical FTAI. This finding was also identified in the previous ancillary 
analysis, reported in Chapter 3, where females that did respond to GnRH within the G1-
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2PG treatment group had elevated plasma progesterone concentrations within the 
same time frame. However, since no animals underwent FTAI, it is hard to speculate 
what the effect would be on FTAI pregnancy rates or early embryonic loss. This is 
especially difficult since all animals reached 1.0 ng/ml plasma progesterone 
concentrations 4 d following theoretical FTAI. 
The second experiment was designed as a follow-up study to Chapter 3 with 
continuation of ovarian parameter analysis, but more importantly to observe the effect 
of G1 removal on FTAI pregnancy rates on a larger scale. Therefore, 2159 lactating, 
multiparous beef cows from 11 herds across 5 universities were combined to create a 
field study of effects on pregnancy rates. Also, a subset of cows across 3 universities 
were used to further study the effects of G1 removal from the 5dCO on ovarian 
parameters in Chapter 4. It is interesting to note that although there were no statistical 
differences in proportion of animals displaying behavioral estrus, NoG1-1PG did have 
significantly more advanced (lower) estrous detection aid scores than both G1-2PG and 
NoG1-2PG. However, the more advanced estrous detection aid scores did not extend to 
increased FTAI pregnancy rates as there were no differences in FTAI pregnancy among 
treatments. Although NoG1-1PG had the more advanced estrous detection aid scores 
(and possibly increased estradiol concentrations), it was NoG1-2PG that had the 
significantly larger dominant follicles upon CIDR removal when compared to the other 
treatment groups. Therefore, indicating the larger dominant follicles within the NoG1-
2PG treatment group may not have been as estrogenic as the smaller dominant follicles 
of G1-2PG and NoG1-1PG. This finding is in contrast to the data presented in Chapter 3, 
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where the NoG1-2PG group had the significantly higher peak estradiol concentrations 
prior to theoretical FTAI and no differences were identified in dominant follicle diameter 
at any time point. The differences between the two experiments in this thesis are likely 
due to sample size with increased statistical power in Chapter 4. 
Similar to Dias et al. (2014), females not responding to G1 in Chapter 4 tended to 
have an increased proportion of females displaying behavioral estrus. This increase in 
behavioral estrus is likely due to the increased diameter of not only the dominant follicle 
but also the second largest follicle in females not responding to G1. However, the 
differences in follicle diameter reported within Chapter 4 were unique as both the data 
from Chapter 3 and Dias et al. (2014) showed no differences in follicle diameter prior to 
FTAI in females not responding to G1. Furthermore, it is of interest to note that even 
though animals not responding to G1 had increased dominant follicle diameter and an 
increased tendency to display behavioral estrus, it did not correlate to increased FTAI 
pregnancy rates in this study or as other have reported. The data presented within this 
thesis and by Dias et al. (2014) does indicate that females that do not respond to G1 
administration may potentially benefit through increased follicle diameter, increased 
behavioral estrus, and potential increased FTAI pregnancy rates. However, this same 
benefit is not identifiable when G1 is not administered in Chapter 4. Therefore, potential 
need for research remains in determining why failure to respond to G1 when 
administered in the 5dCO, has a beneficial effect. 
Similar to the ancillary analysis of G1 response from Chapter 3, ancillary analysis 
of animals in Chapter 4 who either did or did not reset their follicular wave upon CIDR 
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insertion resulted in increased follicle diameter upon CIDR removal, increased 
proportion of females displaying behavioral estrus, and more advances estrous 
detection aid scores. The findings of the ancillary analysis indicate that the 5dCO has 
added benefits to animals that do not reset their follicular wave; however, this does not 
correlate to increase FTAI pregnancy rates. It is unique that the increased follicle size 
and behavioral estrous response rates are not identifiable when G1 is not administered, 
as in the field study. This would further enhance the argument, presented previously, 
that failure to respond to G1 had additional benefits on ovarian parameters. Therefore, 
a need remains for further research to determine the exact effects that failure to 
respond to G1 has and what leads to the benefits seen upon ovarian parameters versus 
when no G1 is administered.  
Based upon the data presented in this thesis, G1 removal from the 5-d CO-Synch 
+ CIDR protocol does not have detrimental effects upon ovarian parameters or fixed 
time artificial insemination rates. However, multiple points of interest still remain for 
further study to potentially increase reproductive efficiency in beef cattle. The 
development of an economical chute side test to identify follicular wave stage and 
animals that will or will not need GnRH at the initiation of the 5dCO protocol could 
prove advantageous through potentially increased FTAI pregnancy rates. In addition, 
further research is needed to determine why the increased dominant follicle diameter 
seen within females not responding to G1 administration and increased proportion of 
behavioral estrus, speculated to indicated increased estradiol concentrations, does not 
correlate to the expected increased FTAI pregnancy rates.  
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